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A dramatic reduction in the discovery of new antimicrobial compounds has led 
researchers to search for rare antibiotic-producing species in unexplored habitats. Two 
group of Actinobacteria and Myxobacteria are known as rich sources for bioactive 
secondary metabolites. In order to find rare and novel species of these two groups, some 
under-investigated habitats like the deserts, mangrove forests, beach sands, the soil of 
medicinal plants and freshwater snails were chosen as sources for isolation. Totally, 
108 actinobacterial strains and 36 myxobacterial strains were isolated from soil samples 
(80 isolates of Actinobacteria, 32 isolates of Myxobacteria) and from different genera 
of freshwater snails (28 isolates of Actinobacteria, 4 isolates of Myxobacteria). Whole-
genome sequencing identified six novel species of Actinobacteria belonging to the 
genera Kibdelosporangium (4NS15), Amycolatopsis (Q1), Pseudonocardia (Q2), 
Sanguibacter (NS44ZA), Agromyces (BA) and Streptomyces (7NS3). Analyses of the 
extracts from two isolates 4NS15 and 7NS3 showed good antibacterial activity. Strain 
4NS15, isolated from desert soil could produce a new family of compounds belonging 
to the class of terpenoids. The name Kibdelosporangium persicum sp. nov has been 
proposed for this new representative of the genus Kibdelosporangium. A metagenomic 
approach using cultivation‐independent high‐throughput sequencing revealed that the 
phylum Actinobacteria in the freshwater snail Physa acuta represented only 2% of the 
bacterial community. However, an isolated strain 7NS3 from this freshwater snail was 
detected as a novel Streptomyces species. Bioassay-guided high performance liquid 
chromatography (HPLC) and high-resolution electrospray ionization-mass 
spectrometry (HR-ESI-MS) analyses of its crude extract fractions resulted in the 
detection of a compound, which showed match characteristics with the already known 
compound emycin A, an angucycline aromatic polyketide. Our study demonstrates that 
with targeting unexplored habitats, we can still isolate novel species that potentially 
produce novel secondary metabolites. 
 







Ein drastischer Rückgang bei der Entdeckung neuer antimikrobieller Substanzen 
veranlasste Forscher dazu, nach seltenen Antibiotika-produzierenden Arten in noch 
unerschlossenen Habitaten zu suchen. Zwei Gruppen von Actinobakterien und 
Myxobakterien sind als ergiebige Quellen für bioaktive Sekundärmetabolite bekannt. 
Um neue und seltene Spezies dieser zwei Gruppen zu finden, wurden einige bislang 
wenig untersuchte Lebensräume wie die Wüste, Mangrovenwälder, Strandsand, 
Heilpflanzen und Süßwasserschnecken als Quellen für die Identifizierung ausgewählt. 
Insgesamt wurden 108 Actinobakterienstämme und 36 Myxobakterienstämme aus 
Bodenproben (80 Isolate von Actinobakterien, 32 Isolate von Myxobakterien) und aus 
verschiedenen Gattungen von Süßwasserschnecken (28 Isolate von Actinobakterien, 
vier Isolate von Myxobakterien) isoliert. Durch vollständige Genomsequenzierung 
konnten sechs neue Spezies der Actinobakterien, welche zu den Gattungen 
Kibdelosporangium (4NS15), Amycolatopsis (Q1), Pseudonocardia (Q2), 
Sanguibacter (NS44ZA), Agromyces (BA) and Streptomyces (7NS3) gehören, 
identifiziert werden. Die Analyse von Extrakten zweier dieser Isolate zeigte gute 
antibakterielle Aktivität. Stamm 4NS15, isoliert aus Wüstenboden, konnte eine neue 
Gruppe von Verbindungen produzieren, die zur Familie der Terpenoids gehören. Als 
Name für diesen neuen Vertreter der Gattung Kibdelosporangium wurde 
Kibdelosporangium persicum sp. nov vorgeschlagen. Ein metagenomischer Ansatz mit 
kultivierungsunabhängiger Hochdurchsatzsequenzierung ergab, dass das Phylum 
Actinobacteria in der Süßwasserschnecke Physa acuta nur zwei Prozent der 
bakteriellen Population ausmacht. Jedoch wurde der aus dieser Süßwasserschnecke 
isolierte Stamm 7NS3 als neue Streptomyces-Spezies identifiziert. Wirkorientierte 
Hochleistungsflüssigkeitschromatographie (bioassay-guided high performance liquid 
chromatography, HPLC) und hochauflösende Elektrospray-Ionisations-
Massenspektrometrie (HR-ESI-MS)-Analysen seiner Rohextraktfraktionen führten 
zum Nachweis einer Verbindung, die Übereinstimmungen mit der bereits bekannten 
Verbindung Emycin A, einem angucyclin-aromatischen Polyketid, aufwies. Unsere 
Studie zeigt, dass wir mit der gezielten Suche in unerforschten Habitaten immer noch 
neue Arten isolieren können, die möglicherweise neue Sekundärmetaboliten 
produzieren.  
Stichworte:  Seltene Actinobakterien, Iran, unerforschte Habitate, 







1.1 Antibiotics and natural products 
The invention of microscope by van Leeuwenhoek, yielded in identification of bacteria 
in the 1670s but the connection between bacteria and diseases found in nineteenth 
century by Robert Koch (1). As a result, one of the fundamental accomplishments of 
human kind in the history of medicine was the discovery of antibacterial substances (2). 
The term “Antibiotics” was first used by Selman Waksman in 1941 and described a 
small molecule produced by microorganisms with antagonistic characteristic on the 
other microbe growth (3). This definition of antibiotics was brought in 13 years after 
the first observations of penicillin (3). The accidental observation of Alexander Fleming 
on the growth inhibition of Staphylococci by mold colonies in 1928, had a great impact 
on the future of antimicrobial discovery (4). After eleven years from Fleming’s 
discovery, three scientists named Howard Florey, Norman Heatly and Ernst Chain 
could purify and scale up penicillin for clinical usage in 1939 (4). The revolution of 
human medicine and the path towards golden era, started by Waksman research on soil 
(5). Waksman and his team discovered the significance impact of soil bacteria 
(actinomycetes) on inhibiting the growth of other bacteria in a competitive atmosphere 
that leads to introducing the concept of ‘Waksman platform’ in 1938 and the definition 
of antibiotics in 1941 (4). Waksmans team screened soil-derived streptomycetes for 
antimicrobial activity by detecting inhibition of growth zones on plates and this work 
was adopted by the pharmaceutical industry and the results initiated ‘the antibiotic 
golden era’ (6).  
Over the next 20 years (1940s until 1960s), the major classes of antibiotics were 
discovered and one-half of them are still in clinical use (Figure 1-1). Although many of 
the discovered antibiotics saved the patient’s lives (especially the role of penicillin on 
treatment of the infections from second world war soldiers), shortly thereafter antibiotic 
resistance crisis happened (7). Unrestricted use of antibiotics and the reduction in 
antibiotic discovery from the 1970s brought the need of finding new antibiotics. Two 
main reasons eliminated the golden age of antibiotic discovery: First, easy-to-find 
antibiotics had been discovered and for finding new classes of antibiotics, scientists 
required more effort and clever thinking. Second, from commercial point of view, the 
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benefit of selling antibiotics for pharmaceutical companies was low and they lost their 
interest in new investments, because new antibiotics have been used just in serious 
infections (2).  
Entering next era known as antibiotic medicinal chemistry era from mid 1960s to 2000s 
started with a gap in finding new antibiotics by Waksman platform and caused 
designing semi-synthetic and entirely synthetic antibiotics (4,8). Although finding the 
new semi-synthetic derivatives was an outstanding improvement but it brought next 
era, which lasted until now and we have known it as era of antibiotic resistance (8). 
Specialists are worried that we return to the pre-antibiotic era due to spread of multidrug 
resistant (MDR) strains (9). Multidrug-resistant (MDR) pathogens, like carbapenem-
resistant Pseudomonas aeruginosa, vancomycin-resistant enterococci (VRE), 
methicillin-resistant Staphylococcus aureus (MRSA), and extended-spectrum β-
lactamases (ESBL) are of the most problematic for healthcare (9).  
 
Figure 1-1 Timeline for the antibiotics introduction in different era (adapted from reference (10)) 
 
Nine most important antibiotic classes are beta-lactams (penicillin), tetracycline, 
macrolides (erythromycin), glycopeptides (vancomycin), aminoglycosides 
(gentamicin), lincosamides (clindamycin), sulfonamides (sulfamethizole), 
oxazolidinones (linezolid) and fluoroquinolones (ciprofloxacin)(Figure 1-2). Among 
them three classes, sulfonamides, fluoroquinolones, and oxazolidinones, entirely 
formed from synthetic chemistry. The semi-synthetic derivatives of penicillin formed 
beta-lactams as an entire class of antibiotics (4). In spite of drug developments and new 




Figure 1-2 Nine classes of antibiotics (11) The mechanism of their action showed by color codes.  
 
The effort of investing in high-throughput screening (HTS) programmes to find new 
synthetic antibiotics were unsuccessful. For instance among 500 000 compounds 
screened by GlaxoSmithKline (GSK) using HTS, no candidates were chosen for 
development (11). For this reason, the old interest of scientists for natural products 
came up (10).  
Most current antibiotics derived from natural products and their main mechanism of 
actions are inhibition of protein, cell wall and DNA/RNA synthesis (Figure 1-3) (12).  
The bacteria can require their resistance through two paths:  
1) Biochemically: That caused by antibiotic inactivation (redox process, 
hydrolysis), target modification (protein structure interference, peptidoglycan 
structure alteration) or pumps permeability changes. 
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2) Genetically: That caused by chromosomal mutations (spontaneous, adaptive) or 
horizontal gene transfer including transduction (bacteriophage), conjugation 
(plasmids or transposons) or transformation (incorporation into the 
chromosome of chromosomal DNA or plasmids)(2).  
 
Figure 1-3 Schematic representation of the three major mechanisms of action of widely used 
antibiotics (12) 
 
Natural products are chemical compounds isolated from different alive creatures and 
can be primary or secondary metabolites. Primary metabolites are necessary for 
bacterial growth, development and reproduction and include proteins, nucleic, 
polysaccharides, fatty acids, etc.)(13). Secondary metabolites, which produce in 
stationary phase of growth, are often species specific and are not directly essential for 
growth but involve in multiple functions such as protection (to kill competitors) or 
communication (signaling molecules between species or mediate interaction with 
eukaryotic hosts)(11). They can act as dyes/colorants, toxins, hormones, vitamins, 
cofactors, pharmacologically active agents and antibiotics (14). 
1.2 Dereplication 
A rising problem with isolating natural products was undesirable duplications for 
instance, echinomycin, toyocamycin, etc. were discovered independently over 8 to 10 
times and named differently (13). That brings an essential element as screening 
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strategy, to detect secondary metabolite as a new metabolite or as an identical one with 
what previously published (13). This strategy named dereplication, which was 
developed by scientists to speed up the natural product discovery, mostly  from 1993 
until 2014 (15). Dereplication simply means discarding of known compounds (15). It 
is an approach combining chromatographic or spectroscopic methods with internal and 
external databases to allow us to identify new secondary metabolites (16). Chapman & 
Hall’s Dictionary of Natural Products (DNP), AntiBase, MarinLit and Myxobase are a 
number of examples for databases or libraries containing thousands of studied natural 
products (16). More than two thirds of publications between 2005 and 2015, 
incorporated the dereplication subject (15). 
Is there any limit in finding new microbial compounds? The sources for natural 
products in the microbial world are significantly unexplored (13). 
1.3 Good producers of natural products 
Most focus in natural-product discovery has been on the actinomycetes, as they produce 
45% of all bioactive microbial metabolites (13). But there are also some Gram-negative 
and Gram-positive representatives that are good antibiotic producers such as: 
Pseudomonas and Bacillus species (13). Recently, Myxobacteria from the phylum 
Proteobacteria have become one of the top producers of natural products (17). 
1.3.1 Myxobacteria 
The first myxobacterium was discovered in 1809 and initially introduced as fungus 
named Polyangium vitellinum by H.F. Link (18). Eighty-three years after Link’s 
discovery in 1892, Ronald Thaxter described different species and myxobacterium 
identified as bacteria. Thaxter’s accurate description of Chondromyces crocatus and 
other relatives’ unicellular vegetative stage, locomotion, swarming, aggregation and 
fruiting body formation validated for the next 100 years (19). 
Myxobacteria are Gram-negative and δ-proteobacteria belonging to the order 
Myxococcales. Previously, the order of Myxococcales consisted of 55 species including 
28 genera (20) (Figure 1-4), but until 2018, these numbers increased to 30 genera and 




They have rod-shaped vegetative cells and three famous capabilities: 
 Their ability to glide and make film-like swarms spread over solid surfaces.  
 Their social life and sophisticated intercellular communication systems that 
bring them all together in large population in their habitats, e.g. soil, wood, 
dung, etc. 
 Their unique morphogenetic potential in starvation conditions, which lead to 
form a multicellular, species-specific ‘Fruiting-bodies’ (22). 
 
Figure 1-4 Current taxonomy of the order Myxococcales (adopted from reference 20) 
 
Myxobacteria can be divided in two groups of predators and cellulose decomposers. 
For isolating predators, living E. coli is used as the only source of C and N and for the 
decomposers, filter paper is used. Degradation of large molecules like cellulose or 
microbial cells require sufficient and large population that can be seen in myxobacteria 
and let them leave behind many competitors (23). 
Other interesting features of them including their large genome, which range in size 
from 9.0 Mbp to 16.0 Mbp (24) and their extraordinary ability of producing diverse 
bioactive secondary metabolites (25). Until 2018, from 9000 strains of myxobacteria, 
more than 100 new carbon skeleton secondary metabolites and 600 derivatives have 
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been isolated (26). Sorangium, Myxococcus and Chondromyces are the genera with the 
most isolated natural products (25). The first antibiotic discovery of myxobacteria with 
antifungal activity was in 1977.  Ambruticin was isolated from a strain of Sorangium 
cellulosum (Polyangium cellulosum) by Connor et al. (20). Clinically used natural 
products isolated from the same species (Sorangium cellulosum So ce90) are 
Epothilone A and B, which are distinguished by their antifungal and cytotoxic activity 
but nowadays use for cancer treatment (27). 
1.3.2  Actinobacteria 
One of the largest taxonomic bacterial phylum, which inhabitants of soil, aquatic 
environments, plant symbionts, animal pathogens and human or animal gastrointestinal 
commensals, is the phylum Actinobacteria (28). These Gram-positive bacteria have 
diverse morphological, physiological and chemotaxonomic properties. The phylum 
Actinobacteria consists of 6 classes including Actinobacteria, Acidimicrobiia, 
Coriobacteriia, Nitriliruptoria, Rubrobacteria, and Thermoleophilia, 5 subclasses, 6 
orders, and 14 suborders. The order Actinomycetales belongs to the class 
Actinobacteria and constitute 43 families (29). Initially they were considered as fungi 
and their name derives from the Greek words of ray (aktin) and fungi (mukes). This 
phylum involved two main groups defined as Streptomycetes and non-Streptomycetes 
(30). Actinobacteria have a range of life cycles but the best-studied of them was in 
Streptomyces coelicolor A3 (28). The Streptomyces life cycle begins with spore 
germination and grow until they form substrate mycelium. Due to stress or lack of 
nutrition, they will form aerial hyphae, which undergo cell division to form spores 
(Figure 1-5)(31).  
 Substrate mycelium: Known also as primary or vegetative mycelium is 
absorbing nutrients from medium (by getting in to medium or on the surface). 
 Aerial mycelium: The hyphae that substrate mycelium develops upright on the 
surface of the medium mainly to produce reproductive spores. 
 Spores: Spores may be formed on the substrate or aerial mycelia as single cells, 
chain of spores or in vesicles (sporangia) in limited nutrition condition to rescue 




Figure 1-5 Life cycle of Actinobacteria (28) 
 
The nomenclatural and classification of the phylum Actinobacteira were very 
challenging (29). The earliest genus described by Cohn in 1875 was Strepthrotrix (29). 
Until 1920s naming in taxa or species of this phylum was a major issue. The names 
were assigned between fungi and bacteria. In 1950 Waksman listed 31 synonyms of 
names for actinomycetes (29). The lack of an international agreement for classification, 
made a confusion in establishing new actinomycetes. The confusion solved partly in 
the eighth edition of Bergey’s Manual of Determinative Bacteriology. This is the 
standard reference for bacterial taxonomy (29). Afterwards the establishment of 
Approved Lists of Bacterial Names by Skerman in 1980 made a turning point in 
bacterial taxonomy. Based on that, just the validly described taxa by an international 
committee of microbiologists were recognized and added to the list. However after 
1980, the taxonomic rearrangements at the genus and family level started, due to 
chemotaxonomic analysis or 16S rRNA sequencing, identification became challenging 
(29).   
1.4 Polyphasic taxonomy 
Microbial taxonomy or microbial systematics relies on three main elements: 
characterization classification and nomenclature (32). The term nomenclature defines 
as choosing name or labeling in a particular specialist field, which depends on 
classification. The information, which gathered from characterization is needed for 
classification (32). The polyphasic taxonomy approach currently used in the 
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characterization of a novel bacterium includes a combination of phenotypic, 
chemotaxonomic and genotypic data (33). 
Initially, classification was based on phenotypic markers such as morphology or growth 
conditions. Later, biochemical and physiological aspects were added and until 1980s, 
the development of sequencing techniques (in particular 16S rRNA gene amplification) 
facilitated bacterial classification (34). Although from mid-1990s, whole-genome 
sequencing caused a revolution in taxonomy, but still routine identification of bacterial 
strains is needed to fulfil the requirements in assigning a novel taxon (34). 
For establishing reliable identification of new species, especially in the phylum 
Actinobacteria (with 29 orders and 62 families), the polyphasic approach is a crucial 
step.  
1.4.1 Phenotype 
Phenotype is the observable expression of genotype and it includes morphological, 
biochemical and physiological properties of the organism (33).  
1.4.1.1 Morphology 
The phylum Actinobacteria has the richest morphological differentiation (30). The 
methods applied for analysis of morphology, including colony and pigment formation, 
aerial and substrate mycelium observation, are conducted by culturing the 
Actinobacteria on ISP plates (International Streptomyces Project media). Complicated 
structures such as spore, spore chain and sporangia can be observed by scanning 
electron microscopy (SEM). Cellular morphology can vary from coccoid 
(Micrococcus) to highly branched mycelia (Streptomyces) or elongated filaments 
(Rhodococcus)(28). Spore formation is important in the taxonomy of Actinobacteria, 
they can be formed as single cells or chains on the substrate and/or aerial mycelium or 
in special vesicles (sporangia). As examples, the genera Streptomyces, Kitasatospora 
and some Nocardia spp. have long chains of spores, the genera Actinomadura, 
Saccharopolyspora and Nocardia spp. produce short chains of spores. Frankia and 
Kibdelosporangium keep their spores in sporangia, which looks like bags (26). 
Melanoid pigments are also important in taxonomic studies. These metabolic polymers 





Chemotaxonomical characteristics relates to distribution of chemical markers of the cell 
envelope. The amino acids in cell-wall, sugars in whole-cell and lipids, menaquinones 
and fatty acid in plasma membrane (26). 
Amino acids: Identification of different amino acid sequences of the tetrapeptide side 
chain of peptidoglycan, the mode of cross-links between the chains like the presence or 
absence of glycine in interpeptide bridges or the presence of diaminoacids at position 3 
of the peptide chain like 2,6-diaminopimelic acid (DAP), give important information 
for classification of Actinobacteria (28,35,36). 
Sugar: The actinobacterial species divided in 5 groups based on the presence of 
different sugars in their whole-cell (26,33): 
A) Group A contains arabinose and galactose 
B) Group B madurose (3-O-methyl-D-galactose) 
C) Group C no diagnostic sugars 
D) Group D arabinose and xylose 
E) Group E galactose and rhamnose 
Phospholipids: Based on major phospholipid markers in plasma membrane, 
Actinobacteria have been classified to five groups (33). 




PⅠ No nitrogenous phospholipids 
PⅡ Only one nitrogenous phospholipid phosphatidylethanolamine 
PⅢ Phosphatidyl choline and characteristic phospholipid 
PⅣ Glucosamine-containing phospholipids 
PⅤ Phosphatidylglcerol and glucosamine-containing phospholipids 
 
Menaquinone: Among detected respiratory isoprenoid quinones, which play an 
important role in the electron transport chain, menaquinones are most commonly found 
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in actinomycete cell envelope. the length of isoprenoid side chain, and the number of 
saturated isoprenoid units are important in classification (36). 
 
Fatty acids: Fatty acids are found in cytoplasmic membrane of bacteria, lipoteichoic 
acids of Gram-positive and lipopolysaccharides of Gram-negative bacteria. Carbon 
chain length, presence of methyl groups, saturated and unsaturated fatty acids, 
cyclopropane or hydroxyl fatty acids are important in taxonomic classification (37). 
 Enzymology 
There are some enzyme tests that are helpful in polyphasic taxonomy. For instance 
respiratory enzyme tests (oxidase), catalase or hydrolysis of polymers (cellulose, 
gelatin, starch, etc.). 
1.4.1.3 Physiology 
Utilisation of different carbon sources, optimal temperature and pH value, resistance to 
sodium chloride are helpful factors in differentiating between all species of 
Actinobacteria. 
1.4.2 Genotype 
The genotype is as important as phenotype in description of bacteria. 16S rRNA gene 
sequencing,  DNA-DNA Hybridization (DDH), Average Nucleotide Identity (ANI), 
G+C content and whole-genome sequencing are the current methods for identifying 
bacterial species (37). DNA–DNA hybridization techniques (Brenner et al., 1969; 
Johnson, 1991) and chemotaxonomy were used for bacterial taxonomy between 1960s 
and the 1980s. Later, DNA amplification and sequencing techniques (specifically 16S 
rRNA gene sequencing) facilitated bacterial classification (34). In the mid-1990s, 
whole-genome sequencing provided complete genome information of the strain. But 
still identification of a bacterial strain is depending on comparing phenotypic and 
genotypic characteristics of new strain with previously described species (34).  
1.4.2.1 16S rRNA gene  
The 16S rRNA gene (1650 bp) is one of the three kinds of bacterial ribosomal RNA 
molecules (5S, 16S, 23S), which has highly conserved nature and is used as marker for 
microbial taxonomy. 16S rRNA gene sequences of related species can be retrieved from 
databases like Ribosomal Database Project II (http://rdp.cme.msu.edu/) and GenBank 
(http://www.ncbi.nlm.nih.gov/). Phylogenetic analysis can be performed after 
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alignment of 16S rRNA gene sequence using software packages such as BLAST and 
CLUSTAL X (33). Phylogenetic tree constructional is using  software such as PAUP, 
PHYLIP, MEGA 4 or the DSMZ phylogenomic pipeline of the Genome to Genome 
Distance Calculator (GGDC) server available at http://ggdc.dsmz.de/ (38). 
Stackebrandt and Goebel recommended a 97 % 16S rRNA gene sequence similarity 
threshold for same species in 1994, whereas today the cut-off identity value for new 
species is 98.7% (39). Step-by step procedure for taxonomical characterization of newly 
isolated strains, deposition in culture collection centers and publication is shown in 
Figure 1-6. 
 
Figure 1-6 Flow diagram of  procedure for taxonomical characterization of newly isolated strains 
adopted from (33) 
 
1.4.2.2 DNA-DNA hybridization (DDH) 
DNA-DNA reassociation or hybridization is a technique based on denaturation of DNA 
from two bacterial species in high temperature and then making a hybrid by lowering 
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down the temperature. Bacterial species are detected as new species when their DDH 
value is ≤ 70%.  
DDH value is depends on three parameters (33): 
1) G+C mol % 
2) Ionic strength of solution 
3) Melting temperature of DNA hybrid  
Nowadays digital DNA-DNA Hybridizations (dDDH) have more advantages in 
comparison to experimental DDH, because the data are accessible and accumulative on 
available databases (40). 
1.4.2.3 Average Nucleotide Identity (ANI) 
This is a valid alternative to DDH, introduced by Konstantinidis and colleagues (33). It 
is a tool, which gives the mean nucleotide sequence identity of shared genes between 
two strains. The ANI value of 95% corresponds to DDH value of 70%. This tool should 
not be used as a single tool for classification, although there are some examples of novel 
bacteria descriptions with ANI such as Dehalococcoides mccartyi (Loffler et al., 2012) 
and Sphaerochaeta globose (Ritalahti et al., 2012)(34). 
1.4.2.4 G+C content 
The analysis of guanosine and cytosine (mole percent) of DNA is important in bacterial 
systematic. Because the variation of GC content percentage is not more than 3% within 
a well-defined species and not more than 10% within well-defined genera (33).  
1.4.2.5 Whole-genome sequencing 
Over the past few years, Next Generation Sequencing Technologies (NGST) are widely 
used for accurate sequencing of bacterial genomes (41). Previously, there was no need 
to perform whole-genome sequencing for novel species description. Whereas recently, 
the International Journal of Systematic and Evolutionary Microbiology (IJSEM), which 
is famous for publishing new strains description, made it mandatory to do whole-
genome sequencing (http://ijs. 
microbiologyresearch.org/content/Genome_data_required_IJSEM. Accessed 22 April 
2019) (42). One of the databases for genome-based prokaryote taxonomy, which grows 
continuously is the Type (Strain) Genome Server (TYGS) (https://tygs.dsmz.de/)(42). 
This database contains comprehensive information of the genomes of type strains of 
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species and subspecies with validly published names, automatically detection of closest 
neighbors of query genomes and truly whole-genome-based methods for phylogeny 
and classification (40). 
1.4.2.6 MALDI-TOF 
Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) MS spectra 
give some information about ribosomal proteins, which can be used in taxonomy of 
bacteria (43). 
1.4.3 Ecology 
Actinomycetes are ubiquitous and can be found in soil, freshwater and marine 
environments. Beside their interaction with environment, they are welcome guests in 
many other organisms like plants (Streptomyces as endosymbionts and pathogens), 
insects (form mutualistic symbiosis in beewolves, fungus growing ants), marine 
animals (in the microbiome of sponges, sea-cucumbers, seaweeds, cone snails) and etc 
(44). The phylum Actinobacteria is famous for producing antibiotics and in most 
mutualistic symbiosis interactions (45), they have a protective role (46). On the other 
hand, they produce enzymes that degrade resilient biopolymers (42). The most 
important genus in the phylum Actinobacteria is the genus Streptomyces (28). Some 
examples of the biological functions of the interactions between Streptomyces spp. and 
their host organisms are shown in Figure 1-7. 
 
Figure 1-7 Some examples of interactions of Streptomyces spp. with eukaryotic organisms (28) 
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The ecology or specifically the nutrient status of the environment, has a key role in 
producing antibiotics by actinomycetes (44). So it brings the idea of finding known 
species that can produce novel secondary metabolites because of their uncommon 
habitats or apply different isolation methods for focusing on under-investigated species. 
1.4.3.1 Uncommon habitats 
The reduction in discovery of new antibiotics and the rise of rediscovery of known 
strains specially from terrestrial environments, made scientists to think about new 
sources. However, terrestrial microorganisms are still being discovered as novel natural 
product producers. Screening uncommon habitats like mangrove forests, deserts, seas 
etc. may result in discovery of new strains that are more likely to produce new natural 
products (13). 
 Medicinal plants 
Many studies were conducted on Actinobacteria in medicinal plants (47). The use of 
herbal remedies is deeply tied up in culture and medicine especially in Asia (47). Many 
medicinal plants-associated Actinobacteria are able to inhibit or kill pathogenic 
bacteria, fungi or viruses (48). Some novel bioactive compounds isolated from plant-
associated Actinobaceria are shown in Table 1-2. 
Table 1-2 Bioactive compounds isolated from plant-associated Actinobacteria 





























Lupinacidins A and B Anthraquinones (53) 
 Mangrove forests 
Mangroves are defined as tropical trees, which grow between the high spring tide and 
near mean sea levels. They cover almost 75% of the world’s tropical and subtropical 
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coastlines (54). There have been many Actinobacteria isolated from mangrove forests 
but among them five different genera appeared to be valuable sources of potentially 
useful bioactive metabolites (53). Some novel bioactive compounds isolated from 
mangrove forest’s Actinobaceria are shown in Table 1-3. 
Table 1-3 Bioactive compounds isolated from mangrove forest's Actinobacteria 










Hainan Island, South 
China Sea 








β-carboline H1N1 virus (56)(57) 
Salinispora tropica 
CNB-392 
Chub Cay, Bahamas salinosporamide 
A 










nocardiatones A cancer cells (60) 
 
 Deserts 
Although deserts cover one third of earth’s surface, little data are available from new 
chemical compounds produce by Actinobacteria. Because it was believed that such 
conditions like scarcity of water, made life impossible (61). On the other hand, 
scientists thought that there would be no competition that microorganisms were likely 
to synthesize bioactive metabolites (62). But from 2010, after investigating novel 
Actinobacteria isolated from Atacama Desert soil, this belief has been changed (61). 






Table 1-4 Bioactive compounds isolated from Actinobacteria of desert 
Actinobacteria Desert Bioactive 
compounds 
Bioactivity Reference 
Streptomyces sp.  
DB634 























kibdelin Antibacterial (66) 
 
 Freshwater snails  
The interaction of Actinobacteria with vertebrates and invertebrates have been studied 
in different articles. Actinobacteria mostly influence their host’s ecology by different 
functions like producing different enzymes for digestion or protecting the host from 
other pathogens (28). As an example European beewolf that harbors the antibiotic‐
producing “Candidatus Streptomyces philanthi” in antennal glands to protect wasp 
larvae from fungal infections (67). The mutualistic Streptomyces incorporated into 
beewolf cocoons provide a combination of nine antibiotic substances, including 
streptochlorin and a complex of eight piericidin derivatives, which are expected to 
protect the host against the fungal pathogen. In return, the host provides nutrition and a 
competition‐free ecological niche for the bacterium (45).  
Invertebrates are a diverse group of animals that have interaction with useful microbes 
such as Actinobacteria in different ecosystems (68). Although previously insects and 
nowadays marine invertebrates, received considerable attention for their natural 
products but some sources like freshwater snails should not be under-investigated 
(69,70). Freshwater snails are important because they act as intermediate host for over 
10,000 species of trematodes (71). It is believed that the freshwater snails microbiota 
(especially Actinobacteria) can prevent the invasion of pathogenic microbes (70). 
Snail‐associated Actinobacteria were investigated by Peraud et al. in 2009 for the first 
18 
 
time (72). Streptomyces sp. CP32 was isolated as a new strain from the cone snail Conus 
pulicarius and produces the neuroactive thiazoline metabolites pulicatins A‐E (73). 
To our knowledge there are no studies on secondary metabolites produced by 
freshwater snail‐associated Actinobacteria. 
 Physa acuta: It is a globally invasive freshwater snail native to North America (74). 
This small, left-handed, air breathing genus has widespread distribution in all over 
the world and acts as a host for trematodes, causing diseases like echinostomiasis 
and fascioliasis (75). 
1.4.3.2 Selective isolation methods 
It is well-known that only 1% of bacteria on the earth have been cultured. The majority 
of bacteria remain unexplored, mostly due to standard cultivation methods (76). 
Various cultivation methods can lead in the isolation of different groups of bacteria 
(77). Each group of bacteria requires specific growth conditions including different 
temperatures, pH, oxygen level and nutrients. When the artificial medium or incubation 
conditions are different from bacterial requirements, the bacteria will not grow. In some 
cases, the bacteriocins released from other bacteria in a mixed culture inhibit the 
bacterial growth (76).  
Actinobacteria can be divided into two groups: 
Streptomyces 
Non-Streptomyces (Rare Actinobacteria) 
The best strategies to reach a specific group of bacteria (like rare Actinobacteria) are 
(78): 
 Pretreatment methods 
Drying and heating  
Adding chemicals such as phenol and chloramine-T  




 Design of improved selective isolation media 
HV agar: Humic Acid-Vitamin Agar contain humic acid as the sole carbon and 
nitrogen source. Actinomycetes can utilise humic acid to support sporulation (79). 
For eliminating other fast growing bacteria, antibiotics like nalidixic acid can be 
added (78). 
Applying multiple cultivation methods at the same time will robust the chances of 
isolating rare Actinobacteria (76). 
 Rare Actinobacteria 
Rare Actinobacteria referred to strains that are difficult to isolate under normal cultural 
conditions. Currently, the discoveries of new natural metabolites are focusing on non-
Streptomyces or rare Actinobacteria (80). The Streptomyces species produce 7600 
compounds, while rare Actinobateria produce 2500 (13). The compounds produced by 
rare Actinobacteria are diverse, unique, complicated and mostly show low toxicity and 
high antibacterial activity (13), for instance, rifamycins, erythromycin, vancomycin, 
gentamicin are produced by Amycolatopsis mediterranei, Saccharopolyspora 
erythraea, Amycolatopsis orientalis and Micromonopsora purpurea respectively. 
Figure 1-8 shows the relative distribution of the bioactive compounds produced by rare 
actinomycetes, which are described by The Advanced Biological Laboratories (ABL) 
Database (81). 
 




1.5 Aim of study 
The aims of this study step by step are concluded as: 
 Isolation of Actinobacteria and Myxobacteria from soil samples collected from 
uncommon habitats of Iran including desert, mangrove forest, medicinal plants and 
from freshwater snails collected in Germany 
 Purification, identification and phylogenetic analysis of isolates 
 Evaluation of antimicrobial activity based on Minimum Inhibitory Concentration 
(MIC) 
 Study the microbiome of one chosen freshwater snail 
 Dereplication (Chemical analysis of crude extracts) 
 Isolation of the potentially new secondary metabolite from novel actinobacterial 
strain 
 Polyphasic taxonomy and characterization of novel strains 













2 Material and methods 
2.1 Media 
All of the used media in this study were listed in Supplementary. 
2.2 Sampling date and locations 
2.2.1 Soil 
Actinobacteria and Myxobacteria were isolated from soil samples collected in different 
cities (Table 2-1) in Iran (in January 2018) and Germany (in August 2019). The samples 
were collected from uncommon habitats like local medicinal plants root (Cities: Yasooj, 
Tafresh), beach sand (Cities: Boushehr, Qeshm) and desert (Cities: Semnan, Kerman, 
Isfahan) (Figure 2-1). 
Table 2-1 List of collected samples with date and country 









Yasooj Plant soil 
Boushehr Beach sand 
Tafresh Plant soil 
Qeshm Beach sand 
Semnan Desert sand 
Isfahan Soil 
Jul-18 Kerman Desert sand 
Mar-19 Saravan Soil 
Lorestan Soil 
Jul-19 Qeshm Beach sand 
Aug-19 Germany Braunschweig Plant soil 
Oct-19 Iran Isfahan Soil 
Figure 2-1 The different sampling sites in Iran (red dots) 
             
Rige jen- semnan desert 
Silver island- Qeshm 




Different genera of freshwater snails (Figure 2-2) were collected during April 2017 to 
August 2019 from six different regions in Iran and Germany (Table 2-2). 
 
Figure 2-2 Some collected freshwater snails 
Table 2-2 List of collected freshwater snails with date and the country of collection 
Date of 
sampling 
Country City Genus of collected snails 
April 2017  Iran (North) 
Mahmodabad  (Rice field) Lymnaea, Physa, Succinea, 
Planorbis, Radix, Thiaridae Chamestan (Forest) 
Chalous (Side road) 
September 
2017 
 Germany  
(Lower Saxony) 
Schladen Planorbis, Lymnaea, Bithynia 
Isingerode  
(Fishing area) 
July 2018  Germany (Hessen) 














 Germany  
(Lower Saxony) 
Braunschweig 









2.3 Isolation and purification 
2.3.1 Myxobacteria 
Myxobacteria grow slowly compared to most soil bacteria. Their swarming behavior 
facilitates the isolation process. To isolate predator Myxobacteria, water-agar plates 
with living E. coli as the only C and N-source were used. Living E. coli must be streaked 
on water-agar plates like a cross and at the end of the cross, soil or snail samples can be 
added. To isolate cellulose degrading Myxobacteria like Sorangium and Byssovorax, 
mineral salt agar plates (Stan 21=ST21) with autoclaved filter paper in the center were 
used (Figure 2-3). The plates were incubated at 30 ˚C for three weeks. Swarms and 
fruiting bodies from water agar and ST21 plates transferred with needle to new plates. 
After several transferring steps, the purification continues on VY/2 plates (Appendix). 
Myxobacterial vegetative cells should be checked under a microscope. The vegetative 
cells are rod shaped without moves (82).  
     
 
                  
Figure 2-3 Isolation of predators (A) and cellulose decomposers (B) 
 
2.3.2 Actinobacteria 
To isolate Actinobacteria, 1 gram of soil was mixed with 10 ml of sterile water in a 15 
ml falcon tube and vortexed. Serial dilution was conducted as follows: 1 ml of the stock 





The routine procedure for isolation was to plate 100 µl of each dilution on medium 5336 
agar supplemented with 1% cycloheximide to reduce fungi contamination. The plates 
incubated for 7 to 21 days at 30 ˚C. The purification continued using GYM medium (78). 
One of the soil samples from a desert in Isfahan, Iran was targeted to isolate specifically 
rare Actinobacteria. For this reason, pretreatment was performed by heating the soil at 60 
˚C for 30 minutes and adding chloramine T (83). Instead of 5336 medium as was used for 
the first isolation step in the routine procedure, Humic acid-vitamin agar (HV), ISP4 and 
ISP2 plates were used (84).  
2.3.3 Myxobacteria and Actinobacteria from snails 
To isolate Myxobacteria and Actinobacteria from freshwater snails, the process differed 
based on the snail size. For instance, the freshwater snail Lymnaea (because of its big 
size) needed to be boiled in water for a minute to take it out of its shell before it could 
be dissected. For all other genera used in this study, boiling was not necessary. The 
whole snails were sterilized for 30 seconds in 70% ethanol. Then they were transferred 
to 1.5 ml Eppendorf filled with 500 µl sterile water and crashed by sterile pestle. 
Afterwards from this homogenized sample, 200 µl applied on 5336 agar medium, water 
agar and ST21 agar.  
2.4 Identification 
 DNA extraction 
To identify microbial strains, DNA was extracted using the Invisorb® Spin Plant Mini 
Kit (Stratec Molecular, Germany) through the following process: from GYM liquid for 
Actinobacteria and from CYH liquid medium for Myxobacteria, 500 µl of medium 
were transferred to a 1.5 ml Eppendorf. For Actinobacteria, one step of homogenizing 
with pestle is needed. Samples were centrifuged for 1 min at 11000 rpm. The 
supernatants were discarded, and 400 µl lysis buffer P and 20 µl proteinase S were 
added. After vortexing the samples, they were incubated at 65 ˚C for 30 min. Then the 
lysis solution was transferred to prefilters and centrifuged for 1 min at 11000 rpm. The 
prefilters were discarded and 200 µl of binding buffer A was added to the samples after 
which the samples were vortexed. The suspension was transferred to a spin filter, 
incubated for 1 min and centrifuged at 11000 rpm for 2 min. 550 µl of wash buffer I 
was added to the filter and centrifuged at 11000 rpm for 1 min. After discarding the 
filtrate, the spin filter was placed into the 2 ml receiver tube. 550 µl of wash buffer II 
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was added and centrifuged at 11000 rpm for 1 min for two times. The drying step 
continued with centrifuging for more than 4 min at 11000 rpm. Then the spin filter was 
placed into a new 1.5 ml receiver tube and 30 µl of the prewarmed elution buffer added. 
After 3 min of incubation, the samples centrifuged for 1 min at 11000 rpm. Finally, the 
extracted DNA was stored at 4 ˚C.  
 PCR amplification 
Amplification of the 16S rRNA gene was achieved with PCR technique and purification 
of the PCR products was carried out using the NucleoSpin® Gel and a PCR Clean-up 
kit. Amplification of the 16S rRNA gene was performed using a special master mix 
JumpStart™ Taq ReadyMix™ (by Sigma-Aldrich). The PCR mixture had a final 
volume of 50 µl and consisted of the following components: 25 µl JSRM, 22 µl H2O, 
1 µl forward 27f (5'-AGAGTTTGATCMTGGCTCAG-3') and 1 µl reverse primer 
1492r (5'-GGTTACCTTGTTACGACTT-3') with 1 µl of the template DNA (Lane, 
1991). The PCR conducted with thermocycler (Eppendorf Thermocycler Mastercycler 
gradient), started with temperature of 95 ˚C for 5 min, followed by 34 cycles of 
denaturation (94 ˚C, 30 sec), primer annealing (52 ˚C, 30 sec) and elongation (72 ˚C, 2 
min). The final elongation reaction was performed at 72 ˚C for 10 min. Samples were 
mixed with a loading buffer and charged with the DNA-dye SYBR-Green and then 
loaded on a 0.8% agarose gel. After running 45 min at 70 V DNA bands were detectible 
under UV light. 
 Purification of PCR products 
To clean up the isolated PCR products, 1 volume of sample with 2 volumes of buffer 
NTI were mixed and placed in a nucleospin® gel column, which was placed in a 
collection tube. After centrifuging for 30 sec. at 11000 rpm, 700 µl of buffer NT3 was 
added and centrifuged. The nucleospin gel column was placed in a 1.5 ml 
microcentrifuge tube and 30 µl buffer NE was added. After 1 min of incubating at room 
temperature, a centrifugation for 1 min at 11000 rpm followed to get the DNA. The 
DNA sequencing was performed by using the 96-capillary-system from Applied 
Biosystems (ABI), 3730xl DNA Analyzer. Additional primers 1100f (5'-
CAACGAGCGCAACCC-3'), 1100r (5'-GGGTTGCGCTCGTTG-3') and 518r (5'-
CGTATTACCGCGGCTGCTGG-3') were used to obtain an almost full-length 16S 
rRNA gene sequence (1459bp). The acquired sequences were assembled using the 
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program Bioedit (version 7.2.6) and later the consensus sequences were compared 
against the EzTaxon Database (85). 
 Phylogenetic analyses 
Calculation of pairwise 16S rRNA gene sequence similarities was performed using the 
EzTaxon server (https://www. ezbiocloud.net) (86) and the maximum-likelihood (ML) 
and maximum-parsimony (MP) trees were carried out using the DSMZ phylogenomic 
pipeline of the Genome to Genome distance calculator server (39) available at 
http://ggdc.dsmz.de/. Muscle (87), RAxML (88) and TNT (89) were used for 
performing multiple sequence alignment. 
2.5 Screening for secondary metabolites 
 Harvesting the metabolite cultures 
For Actinobacteria, the preculture of GYM liquid was used after 7 days. 1:10 of this 
culture was transferred to metabolite production media 5254 and 5294. The cultures 
were incubated at 30 ˚C and 160 rpm on a rotary shaker for 7 days. To get the crude 
extract of the cultures, 20 ml of the culture was mixed with 20 ml of ethyl acetate and 
shook for one hour and centrifuged at 9000 rpm for 15 min. The upper phase was 
transferred in a round-bottom flask and evaporated with a rotary evaporator (Heidolph 
Laborata 4003). The crude extract was dissolved in 200 µl of methanol.  
For Myxobacteria, H-medium was used as a preculture medium. After 2 weeks of 
incubation at 30 ˚C and 160 rpm, 1:10 of the cultures was transferred in 100 ml of 
different production media like POL, P and Myxoverisin with 2% XAD adsorber-resin. 
For screening secondary metabolites from the genus Myxococcus, POL, P and 
Myxoverisin media were used. For genera Corallococcus, Archangium, Sorangium, 
Hylangium and Nanocystis, POL, P, Myxoverisin and E medium were used. Cultures 
were harvested after 10 days of incubation. The cultures were sieved with a 200 µm 
sieve. XAD was transferred to a flask and filled with 70% acetone and left for one hour. 
After evaporating, the crude extract was dissolved in methanol. 
 Antimicrobial test assay 
The crude extracts were screened against nine test microorganisms with Minimal 
Inhibitory Concentration (MIC)(90). Tested bacteria included Escherichia coli DSM 
1116, Staphylococcus aureus (Newman), Mycobacterium smegmatis ATCC 700084, 
Citrobacter freundii DSM 30039, Pseudomonas aeruginosa PA14, Bacillus subtilis 
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DSM 10T and tested fungi as Wickerhamomyces anomala DSM 6766, Mucor hiemalis 
DSM 2656T and yeast Candida albicans DSM 1665. 
The MIC was determined by using the final concentration of 1 mg/ml of crude extract 
with seven 1:2 serial dilution steps in 96‐well microplates. Mueller Hinton Broth 
medium (MHB: 0.5% casein peptone, 0.5% protease peptone, 0.1% meat extract and 
0.1% yeast extract, pH 7.0) was used for bacteria and MYC medium (1.0% glucose, 
1.0% phytone peptone and 50‐mM HEPES (11.9 g/l) for fungi. 20 μl of crude extract 
was added to the first row of wells, which contained 280 μl of bacterial/fungal 
suspension. After mixing, 150 μl was withdrawn and transferred to the next row of 
wells. This was repeated sequentially up to the last well. A dilution gradient of 66.6, 
33.3, 16.6, 8.3, 4.2, 2.1, 1.0 and 0.52 μg/ml was obtained by discarding 150 μl from the 
last well. All plates were placed on a microplate shaker incubated for 24 h at 650 rpm 
at 30 °C for all plates except M. smegmatis ATCC 700084 and E. coli DSM 1116, which 
were incubated at 37 °C. The MIC values were defined as the lowest concentration of 
the tested extract where the growth of the tested microorganisms was not visible to the 
naked eye.  
 Detection of potential compounds 
Later, the crude extracts with antibacterial activity were fractionated using Reversed‐
Phase HPLC (RP‐HPLC) on an Agilent 1100 HPLC system equipped with an 
XBrigde® (Agilent Technologies, Santa Clara, CA, USA) C‐18 3.5μm, 2.1mm × 
100mm, Waters column. The fractions (0.15 ml) in the 96‐well plates were collected 
by the HPLC column every 0.5 min and were later dried for 45–60 min at 40 °C using 
heated nitrogen. Afterwards, each well was filled with 150 μl of the bacteria, which the 
crude extract showed activity against. Crude extracts were analysed by HR‐ESI‐MS 
(high‐resolution electrospray ionization‐mass spectrometry) using the following setup: 
An HR‐ESI‐MS  Agilent 1200 system coupled to a DAD (Diode‐Array Detection) and 
a maXis ESI TOF (time of flight) mass spectrometer (Bruker Daltonics, Bremen, 
Germany), scan range 100–2500 atomic mass unit (amu), rate 2 Hz, capillary voltage 
4500 V and drying gas temperature 200 °C using the following HPLC conditions: C18 
Acquity UltraPerformance Liquid Chromatography (UPLC) Ethylene Bridged Hybrid 
(BEH)(Waters) column (2.1 × 50 mm, 1.7 μm), solvent A: H2O + 0.1% formic acid 




to 100% B in 20 min, maintaining isocratic conditions at 100% B for 10 min, flow = 
0.6 ml/min and UV−Vis detection 200−600 nm. Data processing and analysis was done 
using data analysis software included in the Compass software from Bruker in order to 
identify the bioactive target masses. The obtained molecular features were matched 
against known actinobacterial compounds from the Dictionary of Natural Products 
(DNP: http://dnp.chemnetbase.com/) and myxobacterial compounds from the in-house 
database (Myxobase)(91). 
2.6 Culture-independent study of freshwater snails 
 Collection and targetting freshwater snails  
Three species of freshwater snails including Lymnaea baltica, Lymnaea stagnalis and 
Physa acuta were collected from a pond (52˚ 6ʹ 42.32ʺ N, 10˚ 40ʹ 46.20ʺ E) in 
Remlingen-Semmenstedt, Germany. The snails were transferred to the laboratory 
within two hours and kept at room temperature. After 24 hours, the snails were washed 
with tap water and sterilized with 70% ethanol to wipe the shells. Snails from the genus 
Lymnaea were taken out of their shells and the snails of genus Physa had their shells 
crashed using a sterile pestle before they were transferred to 1.5 ml Eppendorf tubes 
with 500 µl sterile water. The homogenized samples were used for DNA extraction. 
  DNA extraction and Illumina MiSEQ sequencing and data analysis 
The DNA of three snails was extracted using the PowerSoil® DNA Isolation Kit and 
quantified using a nanodrop (Thermo Scientific)(92). From each snail a part was 
transferred to an Eppendorf, filled with 500 µl sterilized water and homogenized with 
pestle. 250 µl was added to a PowerBead Tube and then vortexed. 60 µl of solution C1 
was added and the suspension vortexed for 10 min. The tubes were centrifuged at 9000 
rpm for 30 sec. Supernatant was transferred to a 2 ml collection tube. 250 μl of solution 
C2 was added to the tube, which was then incubated for 5 min at 2–8 ˚C. After 
centrifuging for 1 min, the supernatant was transferred to a new collection tube. 200 μl 
of solution C3 was added and incubated for 5 min. After centrifuging, 750 μl of 
supernatant was mixed with 1200 μl of solution C4 and 675 μl of suspension, which 
was then transferred to a MB spin column and then centrifuged for 1 min. Now 500 μl 
of solution C5 was added to the spin column and centrifuged for 30 sec. Then the spin 
was placed in a clean 2 ml collection tube and 100 μl solution C6 was added. After 
centrifuging for another 30 sec, the spin was discarded, and DNA remained in the 
collection tube. The extracted DNA was analysed for microbial diversity at the Leibniz 
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institute DSMZ. For this analysis, amplicons of the V3 region of the 16S rRNA gene 
were prepared with the primer pair 341f and 515r (93). The quality of the Bartram 
libraries was checked with a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, 
U.S.) and the subsequent sequencing was performed in 150 bp paired end mode on a 
NextSeq™ 500 (Illumina®, San Diego, CA, U.S.). The generated sequences were 
processed with an amplicon analysis pipeline after the quality of the raw reads had been 
evaluated by FastQC version 0.10.1 (Simon Andrews; 
http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). After trimming the 
forward and the reverse reads to a length of 130 bp, the raw‐sequence data was purified 
from potential primer dimers by a JAVA program called DimerFilter. Fastq‐join  (94) 
joined the forward and reverse reads with a 20 percent mismatch and a minimum 
overlap of 6 bp. FASTA‐converted sequence files were subsequently checked with 
Uchime (95) against the Gold database provided by ChimeraSlayer (Robert Edgar, 
Drive5, Corte Madera, CA, USA) (http://drive5.com/otupipe/gold.tz) and the RDP 
classifier 2.10.1 (93). The RDP classifier 2.10.1 with a confidence value of 0.5, which 
is recommended for short read amplicon data, was employed to perform taxonomic‐
dependent analyses of the bacterial community (96). V3 amplicon data was deposited 
at NCBI SRA (Sequence Read Archives) under accession number PRJNA665462. 
SRA. 
2.7 Selection of bacteria 
2.7.1 Actinobacteria 
16S rRNA gene sequence data provides an initial indication of the taxonomic status of 
a strain. Considering the low amount of similarities between this specific gene and the 
bioactivity screening of the crude extracts obtained from them, fifteen candidates, were 
chosen for further studies. For five strains, whole-genome sequencing and polyphasic 
approach were performed. These strains are highlighted in red color in Table 2-3. 
Table 2-3 List of targeted samples of Actinobacteria 
Targeted samples Similarity  16S rRNA (complete) 
NS40 Streptomyces badius                 98.55 
NS36 Lentzea violacea                       99.10 
NS66 Amycolatopsis albidoflavus      99.79 
NS37 Nocardiopsis umidischolae       99.58 
NS38 Nonomuraea harbinensis          99.65 
30 
 
NS25 Actinomadura apis                    99.23 
Q1 Amycolatopsis rifamycinia        99.03 
Q2 Pseudonocardia cypriaca          99.65 
NS34 Kribbella pittospori                   99.85 
NS59 Streptomyces specialis                 98 
NS44 Herbidospora sakaeratensis      97.64 
44ZA Sanguibacter keddieii                98.34 
BA Agromyces persicus                   99.08 
Sef Prauserella alba                          100 
4NS15 Kibdelosporangium persicum     98.96 
 
All close phylogenetic relatives of the targeted strains Q1, Q2, 44ZA, BA, 4NS15 were 
obtained from the German Collection of Microorganisms and Cell cultures (DSMZ) 
and wink compendium for comparison under the same laboratory condition (Table 2-4). 
Table 2-4 Selected strains and their related type strains 
Genus Strain DSM number close type strains 
Amycolatopsis 
Q1 DSM110486  
 DSM46095 A. rifamycinica 
 SB026  A. rhabdoformis 
 DSM44652 A. kentuckyensis 
 DSM44653 A. lexingtonensis 
 DSM44654 A. pretoriensis 
 DSM44591  A. balhimycina 
Pseudonocardia  
Q2 DSM110487  
 DSM45511 P. cypriaca 
 DSM45671 P. hierapolitana 
 DSM44774 P. zijingensis 
 DSM45352 P. adelaidensis 
Sanguibacter  
NS44ZA DSM110740  
 DSM10542 S. keddieii  
Agromyces  
BA DSM111422 A. persicus 
 DSM26681 A. indicus 
Kibdelosporangium 
4NS15 DSM110728 K. persicum 
 DSM43828 K. aridum subsp. Aridum 
 DSM 44150 K. aridum subsp. Largum 
 DSM44226 K. philippinense 
 DSM104448 K. phytohabitans 
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2.7.1.1 Polyphasic taxonomy 
The workflow for polyphasic taxonomy of newly isolated strains, included genotype 
and phenotype analysis. A flow diagram of the taxonomical characterizations is shown 
in Figure 2-4.  
 
Figure 2-4 Flow diagram for taxonomical characterization of newly isolated strains 
 Genotype 
Genomic DNA of strains was extracted following the protocol described by Jin et al. 
(97). Libraries for Whole-Genome Sequencing on the Illumina platform were prepared 
from extracted genomic DNA applying the Nextera XT DNA Library Preparation Kit 
(Illumina, San Diego, USA). Samples were sequenced using the Illumina NextSeq™ 
500 by GMAK and DSMZ. The digital DNA-DNA Hybridization (dDDH) values and 
G+C content between the genome sequences of strains and their type strains were 
calculated using the Genome-to-Genome Distance Calculator GGDC 2.1 
(http://ggdc.dsmz.de) (42). 
MALDI-TOF/MS analyses were performed in German collection of microorganisms 
and cell cultures (DSMZ) with the type strains. The sample preparation was done by 
applying ethanol/formic acid extraction as described in Protocol 3 of Schumann & 





Phenotype included physiological, morphological and biochemical analysis.  
 Physiology 
The pH range of 5.0 to 10.0 (intervals of 1 pH unit) were determined on GYM agar by 
incubation at 30 ˚C for 1 week. Growth at temperatures of 20, 30, 35 and 40 ˚C were 
observed on GYM agar after incubation for a week. The resistance towards sodium 
chloride is taken out by analysing the growth on basal medium in a 6-well flat bottom 
plate with 0, 2.5, 5, 7.5 and 10 % concentration of sodium chloride respectively(98). 10 
% stock solutions of 10 different carbon sources were added to the basal medium to test 
the ability of strains to utilise them (99). The final concentration of 1% was applied in a 
12-well flat bottom plate. Carbohydrates that were used as carbon sources included: 
glucose, arabinose, sucrose, xylose, inositol, mannitol, fructose, rhamnose, raffinose, and 
cellulose (Figure 2-5).  
        
Figure 2-5 Actinomycetes strain on A) salt plates B) carbon source plates 
 Morphology 
For scanning electron microscopy analysis, a section of the ISP2 and ISP3 plate (1 cm 
x 1 cm) containing bacteria with aerial mycelium were fixed in 5 % aqueous 
glutaraldehyde. The plates were incubated for at least 14 days at 30 ˚C (100). The 
images were recorded with SmartSEM software version 6.06 by Prof. Dr. Manfred 
Rohde, HZI Braunschweig. 
Colony formation, description and melanin production were tested by culturing the 
bacteria on ISP2, ISP3, ISP4, ISP5, ISP6, ISP7 media (International Streptomyces 
Project 2), SSM+T (synthetically Suter medium with tyrosine) and SSM-T (synthetically 




plates were incubated for 10 to 14 days at 28 ˚C or otherwise to the temperature required 
for the given strain. Four parameters, growth, reverse color, aerial mycelium and soluble 
pigment were determined by comparison with the RAL-code (RAL colour code 1005; 
Deutsches Institut für Gütesicherung und Kennzeichnung e. V. – Reichs-Ausschuss für 
Lieferbedingungen)(Figure 2-7). 
 
     
Figure 2-6 Colony description based on RAL(A:GYM, B:ISP2, C:ISP3, D:ISP4, E:ISP5, F:ISP7) 
 
  
Figure 2-7 Formation of melanin pigment (A:ISP6, B:ISP7, C:SSM+, D:SSM-) 
 Biochemistry 
 Enzymology: The enzymatic activities were determined using API®ZYM 
and API® Coryne test strips (BioMérieux) (101,102) 
 Chemotaxonomy: For performing chemotaxonomic analyses like polar 
lipids, fatty acid, cell-wall quinones, sugars and amino acids, freeze dried 
cells are needed. The wet biomass was obtained from 7 days old GYM liquid 
culture by centrifuging at 9000 rpm for 5 min. Cells were harvested and 







Table 2-5 Semiquantitation of enzymatic activities  
API®ZYM  API® Coryne  
Alkaline phosphatase Nitrate reduction 
Butyrate esterase (C4) Pyrazinamidase 
Caprylate esterase lipase (C8) Pyrrolidony arylamidase 
Myristate lipase (C14) Alkaline phosphatase 
Leucine arylamidase β-glucuronidase 
Valine arylamidase β-galactosidase 
Cystine arylamidase α-Glucosidase 
Trypsin N-acetyl-β-glucosamidase 
α-Chymotrypsin Esculin (β-glucosidase) 
Acid phosphatase Urease 
Naphtol-AS-BI-phosphohydrolase Gelatine (hydrolysis) 
α-Galactosidase Glucose fermantation 
β-Galactosidase Ribose fermentation 
β-Glucoronidase Xylose fermentation 
α-Glucosidase Mannitol fermentation 
β-Glucosidase Maltose fermentation 
N-acetyl-β-glucosaminidase Lactose fermentation 
α-Mannosidase Sucrose fermentation 
α-Fucosidase Glycogen fermentation 
 
 
Aminoacid: For amino acids extraction, a 5 mg of freeze-dried sample was hydrolyzed 
in 1 ml of 6N HCl and incubated in a water bath at 100 ºC for 18 h. The hydrolysate 
was dried to remove the HCl and the residue dissolved in 0.3 ml of distilled water. 
Amino acids were identified by Thin Layer Chromatography (TLC) using the solvent 
mixture methanol-water-10N HCl-pyridine (80:17.5:2,5:10 v/v). The paper was 
sprayed with ninhydrin solution and heated at 100 ºC (103). 
 
Sugar: For sugars extraction, a 10 mg (dry weight) sample was hydrolyzed in 1 ml of 
2N H2SO4 and incubated in water bath at 100 ºC for 2 h. The hydrolysate was 
neutralized to pH 5.0 to 5.5 with Ba(OH)2. After centrifuging at 1800 rpm for 5 min, 
the liquid phase was evaporated under reduced pressure and the residue dissolved in 
0.4 ml H2O. The sugars were separated by TLC, using the mixture of solvents consisting 
of ethyl acetate-pyridine-water (3.6:1:1.15 v/v). The plate was sprayed with aniline 




Menaquinone: For menaquinones extraction, a 100 mg of freeze-dried sample was 
mixed with 4 ml methanol-0.3% aqueous NaCl (90:10) and 4 ml petroleum ether. After 
30 min of mixing on a tube rotator, the upper phase was transferred and evaporated at 
30 ºC at reduced pressure. The dry extract was dissolved with 100 μl acetonitrile-
isopropanol (65:35 v/v) (104). Respiratory quinones were analysed by an HPLC 
equipped for diode-array detection and mass spectrometry (HPLC-DAD-MS)(105). 
 
Polar lipids: For polar lipids extraction, a 200 mg of freeze-dried sample was mixed 
with 8 ml of Chloroform-MeOH (2:1) and rotated for 16 h. The suspension was filtered 
with filter paper and evaporated at reduced pressure at 30 ºC. The extract was dissolved 
with 200 μl Chloroform-MeOH (2:1). Two‐dimensional thin‐layer chromatography was 
applied on HPTLC Kieselgel 60F254 (Merck) plates with two mixtures of solvents. The 
mixture of solvents used for the first dimension consisted of chloroform/methanol/water 
(65:25:4 v/v) and the second mixture included chloroform/methanol/ acetic acid/water 
(80:12:15:4 v/v) (105). Detection of polar lipids was surveyed using different reagents 
(Table 2-6). 
 
Table 2-6 List of reagents for phospholipid analysis 
Reagent Composition Heat Identification 
Molybdophosphoric 
acid  
20 % (v/v) in Ethanol  140 °C, 15 min All lipids 
Ninhydrin Merck 6758  100 °C, 4 min Free NH4 
Molybdenum blue Sigma M-3389   Phosphate-
containing 
lipids PO4 
Anisaldehyde 0.5 ml Anisaldehyde, 0.5 ml 
H2SO4,  
9 ml 96% Ethanol  





α-Naphtol-H2SO4 10.5 mL 15 % (w/v) α-
Naphtol in Ethanol, 6.2 ml 




Fatty Acid: For fatty acid extraction, a 10 mg of freeze-dried sample were mixed with 
1ml saponification reagent (45 g NaOH, 150 ml MeOH, 150 ml H2O) and heated in a 
water bath at 100 ºC for 5 min. After vortexing, 2 ml of methylation reagent (325 ml 
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6N HCl, 275 ml MeOH) was added to the mixture. The capped tube was heated at 80 
ºC for 10 min. 1.25 ml of extraction reagent (200 ml hexane and 200 ml Methyl tert-
butyl ether (MTBE)) was added to mixture and rotated for 10 min. After discarding the 
lower phase, 3 ml of washing reagent (10.8 g NaOH, 900 ml H2O) was added to the 
organic phase. After tumbling for 5 min, the upper phase was transferred to a GC vial. 
The GC was performed and analysed using the Sherlock Microbial Identification 
(MIDI) system and the ACTIN version 6 database (106). 
2.7.1.2 Fermentation and compound isolation of strain 4NS15 
 Optimization of medium, volume and harvesting day: 
In order to determine the optimal medium, volume and harvesting day, different 
conditions applied for obtaining the raw extract of strain 4NS15. Four media: 5254, 
5294, 5333 and soy meal were chosen and various volumes: 100, 250, 500, 750 ml and 
1 liter were tested. Growth and production of the specific metabolites were screened on 
different days. From day 7 to 15, the cells were harvested and their crude extract was 
evaluated using HR-ESI-MS. 
 Fermentation: 
To extract the target compounds from the strain 4NS15, 100 ml of 7 days old sub-
cultured GYM broth was inoculated in each 2 L Erlenmeyer flask containing 1 L of 
5294 medium (10 flasks). The cultures were incubated in a rotary shaker at 160 rpm at 
30 ºC for 15 days. A total volume of 10 L was centrifuged and the pellet and supernatant 
separated. 5% XAD 16 was added to the supernatant and left shaking for 24 hours. The 
XAD resin from supernatant was collected by sieving, washed by flushing with distilled 
water, and then extracted three times with methanol. Pellet was extracted with acetone, 
then sonicated, filtered and evaporated in a rotary evaporator. 
 Compound isolation: 
20 µl aliquots of the extracts were injected onto an analytical size luna5µm C18 
(250×4.6 mm) fitted with a guard-column. The compounds were separated by multi 
gradient elution using water with 0.1% formic acid as solvent A and acetonitrile with 
0.1% formic acid as solvent B at a flow rate of 1 ml/minute. The isolation process was 
done in Helmholtz Institute for Pharmaceutical Research Saarland in Saarbrücken 
under supervision of Dr. Emilia Queis. 
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 Cytotoxic assay: 
A cytotoxicity test was conducted for 1 mg/ml of pure compound isolated from 4NS15 
(Fraction 3) in MeOH by applying the MTT method (107). Eight tested cell lines were:  
L-929 (murine fibroblast), KB-3-1 (human cervix carcinoma), A-549 (human lung 
carcinoma), PC-3 (human prostate carcinoma), MCF-7 (human breast 
adenocarcinoma), A-431 (human epidermoid carcinoma), SK-OV-3 (human Caucasian 
ovary adenocarcinoma) and HUVEC (human umbilical vein endothelial cell). Methanol 
was used as a negative control. The cytotoxic assay was performed by Mrs. Wera 
Collisi, HZI-Braunschweig. 
 Structure elucidation: 
To elucidate the structure of the isolated compounds from strain 4NS15, the 
measurements of HRMS, MS2 fragmentation and NMR were performed in HIPS 
(Helmholtz Institute for Pharmaceutical Research Saarland in Saarbrücken) by Dr. 
Emilia Queis. The data is still under investigation by Dr. Lena Keller. 
2.7.1.3 Dead end for two strains NS40 and NS37 
Multilocus Sequence Analysis (MLSA) was done for two strains NS40 and NS37 with 
three housekeeping genes gyrB, atpD and trpB according to Guo et al. (108) (Table 2-7). 
Table 2-7 The list of primers for multi locus sequencing 
Gene  Primer  Sequence (5’ -> 3’)  
atpD  atpDPF (amplification)  
atpDF (sequencing)  
atpDPR (amplification) 



























The PCR amplification were performed using touch down TD60 strategy (109). The 
sequences of the three housekeeping genes were aligned using MUSCLE (multiple 
sequence comparison by log-expectation) (110) in MEGA X software (111). Then 
phylogenetic trees calculations were performed using GGDC. 
 
 NS40 
 Polyphasic taxonomy: 
Polyphasic assays were performed on NS40 and closely related type strains that were 
suggested by the EzTaxon database. Streptomyces badius DSM40139T, Streptomyces 
sindenensis DSM40255T, Streptomyces parvus DSM40348T were obtained from the 
German collection of microorganisms and cell cultures (DSMZ) for comparison under 
the same conditions. DDH has been done by Dr. Kämpfer in Gießen. 
 Antibacterial assay, screening for secondary metabolites and fermentation: 
The antibacterial activity was determined with serial dilution assay. HPLC fractionation 
and LC/MS results were analysed and compared in DNP. To extract the target 
compounds from NS40, the bacterial strain cultured in 50 flasks containing 100 ml of 
5294 medium in 250 ml Erlenmeyer shaken for 7 days at 28 °C (a total of 5 L). After 
centrifugation, 5% XAD was added to the supernatant and left shaking for 24 hours, 
after which XAD was separated and extracted three times with methanol, whereas the 
pellet was extracted with ethyl acetate.  
 NS37 
 Polyphasic taxonomy: 
Some parts of physiology, morphology and biochemistry tests were performed with 
closely related type strains, including: Nocardiopsis umidischolae DSM44362T and 
Nocardiopsis tropica DSM44381T. DDH analysis was done for the strains NS37 and 
DSM44362T in Gießen by Dr.Kämpfer. MALDI-TOF was done for the strain in DSMZ. 
 Antiviral assay 
The antiviral assay was conducted with crude extract of NS37 according to Mulwa et 





 4NSX3  
Among different isolated myxobacteria, strain 4NSX3 was chosen to screen for its 
secondary metabolites. The pure strain was cultured in CYH broth medium. After 10 
days, 10% of CYH transferred to four media: myxoverisin, P, POL and H that contained 
2% XAD. After 10 days of incubation, the XAD in the media harvested with aceton 
and the crude extracts were analysed with HPLC and HR‐ESI‐MS. Later the 
compounds were compared against the Myxobase. 
2.7.3 Actinobacteria from snail 
2.7.3.1 7NS3 
From all 28 isolated Actinobacteria from snails, 7NS3 was chosen for characterization 
and metabolite profiling. The strain 7NS3 was isolated from the freshwater snail Physa 
acuta, which was collected from a pond (52°6′42.32″ N, 10°40′46.20″ E) in Remlingen‐
Semmenstedt, Germany in June 2019. 
 Polyphasic taxonomy 
The whole-genome sequencing was performed in DSMZ and all polyphasic taxonomy 
approaches completed. 
 BGC identification and metabolite profiling 
The potential biosynthetic gene clusters for producing novel compounds from this 
isolate were detected by bioinformatics assay antiSMASH and analysed by Prof. Dr. 











3.1 Soil samples 
3.1.1 Actinobacteria 
Eighty Actinobacteria were isolated from soil samples of nine cities in Iran and the city 
of Braunschweig in Germany (Table S2). The soil samples were collected from 
different plant leaves (Mord, Khesht), the root-soil of special trees and plants (Almond, 
Oak, Astragalus, Safran and Lichen), the sand of beaches and the deserts. Most of the 
isolates were from the city Yasooj, but the most diverse isolation source in terms of rare 
Actinobacteria was the soil sample from the desert in Isfahan because of applying 
pretreatment to the soil. Based on partial 16S rRNA gene sequencing of 80 isolates, 
almost 70% of the isolates belonged to the genus Streptomyces, and the rest were 
characterized as non-Streptomyces (Figure 3-1).  
 
Figure 3-1 Genus-level diversity of Actinobacteria isolated from soil samples 
Among all isolates, fifteen strains that belonged to more interesting families according 
to the taxonomy were chosen for full 16S rRNA gene sequencing (Table 3-1) and 




Streptomyces Lentzea Nocardiopsis Amycolatopsis
Micromonospora Nonomuraea Gordonia Actinomadura
Herbidospora Micrococcus Sanguibacter Pseudonocrdia
Jonesia Glutamibacter Isopetricola Kribella




whole-genome sequencing to characterize as novel species. The list of these top five 
isolates with their accession numbers is shown in Table 3-2. 



















Polyphasic taxonomy, identification or classification is a set of different methods 
applied to get reliable taxonomy of bacteria. In the following part, the results of the 
polyphasic taxonomy (genotype and phenotype), some information about ecology, 
whole-genome sequencing and the ability to produce secondary metabolites of the 
mentioned five top strains are presented.  
 
Targeted samples 16S rRNA Similarity (full sequence %) 
NS40 Streptomyces badius                          98.55 
NS36 Lentzea violacea                                99.10 
NS66 Amycolatopsis albidoflavus               99.79 
NS37 Nocardiopsis umidischolae               99.58 
NS38 Nonomuraea harbinensis                  99.65 
NS25 Actinomadura apis                            99.23 
Q1 Amycolatopsis rifamycinia                99.03 
Q2 Pseudonocardia cypriaca                  99.65 
NS34 Kribbella pittospori                           99.85 
NS59 Streptomyces specialis                         98 
NS44 Herbidospora sakaeratensis              97.64 
44ZA Sanguibacter keddieii                        98.34 
BA Agromyces  arachidis                        99.08 
Sef Prauserella alba                                 100 
4NS15 Kibdelosporangium aridum              98.96 








3.1.1.1 Strains Q1 and Q2 
 Ecology 
Isolates Q1 and Q2 were isolated from silver beach sand in Hengam island located south 
of Qeshm island in the Persian Gulf. The pH of the sand without ion exchanger is 8.49 
and with (CaCl2) is 8.28. 
 Genotype 
 Analysis of the complete 16S rRNA gene sequencing of the two strains Q1 and Q2 in 
the EzTaxon database suggested that they are closely related to the type strains shown 
in Table 3-3. Strain Q1 showed 16S rRNA gene sequence similarity of 99.03% to the 
type strain of Amycolatopsis rifamycinica DSM 46095 and strain Q2 with 99.65% 
showed the highest similarity to Pseudonocardia cypriaca DSM 45511. 
Table 3-3 Q1 and Q2 full 16S rRNA gene sequecning in the EzTaxon database 
Strain Type strains 
Similarity based on 





A. rifamycinica 99.03% DSM 46095 
A. rhabdoformis 98.96% SB026-no DSM 
A. kentuckyensis 98.89% DSM 44652 
A. lexingtonensis 98.82% DSM 44653 
A. pretoriensis 98.75% DSM 44654 




P. cypriaca 99.65% DSM 45511 
P. hierapolitana 99.45% DSM 45671 
P. zijingensis 99.29% DSM 44774 
P. adelaidensis 99.15% DSM 45352 
 
Pairwise 16S rRNA gene sequence similarities, as well as the maximum-likelihood 
(ML) and maximum-parsimony (MP) trees, were carried out using the DSMZ 
phylogenomic pipeline of the Genome to Genome Distance Calculator server (GGDC). 
The results showed that strain Q1 has the highest similarity to Amycolatopsis alba DSM 
44262 (Figure 3-2) and A. rifamycinica DSM 46095 is in a different clade far from Q1. 
On the other hand, strain Q2 showed the highest similarity to P. cypriaca DSM 45511, 




Figure 3-2 Maximum-likelihood phylogenetic tree based on full-length 16S rRNA gene sequence 
of Q1 and most related species. Numbers above the branches are bootstrap support values greater 
than 60% for maximum-likelihood (left) and maximum-parsimony (right) method. Bar, 0.02. 
 
Figure 3-3 Maximum-likelihood phylogenetic tree based on full-length 16S rRNA gene sequence 
of Q2 and most related species. Numbers above the branches are bootstrap support values greater 
than 60% for maximum-likelihood (left) and maximum-parsimony (right) method. Bar, 0.008. 
 
Whole-genome sequencing for both strains were achieved by PacBio-sequencing 
performed in the DSMZ. The draft genome sequence of Q1 has the size of 11.03 Mb 
with an average G+C content of 70,28% and Q2 has 10.32 Mb with 71,77% G+C 
content. Digital DNA-DNA hybridization (dDDH) values (formula d4) showed Q1 is 
related to the type strain Amycolatopsis saalfeldensis DSM 44993T with 29.0% and Q2 
is similar to the type strain Pseudonocardia hierapolitana DSM 45671T with the value 
of 46.1%. 
MALDI-TOF dendrogram results showed Q1 and Amycolatopsis rhabdoformis SB026 
grouped in one cluster with a distance level of 600. Due to lack of data in the database, 
there was no data for the most similar type strains of A. rifamycinica DSM 46095 and 
A. saalfeldensis DSM 44993T. For strain Q2, the d4endrogram showed the highest 
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 Optimal growth for both strains were observed on GYM medium plates at a 
temperature of 30 °C. Both strains have good growth at pH 8, 9, and 10. Q1 was able 
to grow in presence of 5 % NaCl, but Q2 was not able to grow with NaCl. Q1 utilised 
all tested carbohydrates as carbon sources except cellulose (Figure S2). Q2 grew with 
the tested carbon sources, but no growth was seen in plates with raffinose and cellulose 
(Figure S3). 
 Morphology 
No scanning electron microscopy were captured from both strains because they formed 
no aerial mycelium. The special morphology on GYM medium is shown in Figure 3-4. 
Strain Q1 grew well on all ISP plates but no pigment production was seen in ISP 2, ISP 
5, ISP 6, ISP 7, SSM+T and SSM-T media (Figure S4). No growth was observed for 








Q1 and Q2 possessed good enzymatic activities for β-glucoronidase, which showed a 
remarkable difference between the two strains and their type strains (Figure S6). The 
differences in API ZYM and API Coryne are shown in Table 3-4.  














α-chymotrypsin  - + - + + + - 
β-glucoronidase  + - + - - - - 
α-fucosidase  - - - + + + + 
Nitrate 
reduction - - - - + - + 
Esculin  - + + + + + - 
Gelatine 
(hydrolysis) + + + + + + - 
 
For Q2 esculin and gelatin liquefaction was positive, which was different from other 
type strains (Figure S7). Differences in API ZYM and API Coryne are shown in Table 
3-5.  
Table 3-5 Differences in API ZYM and API Coryne of Q2 and relative type strains 
Enyzme Q2 DSM 45511 DSM 45671 DSM 44774 DSM 45352 
Alkaline phosphatase  ++ + + - ++ 
Butyrate esterase (C4)  - + - + - 
α-galactosidase + - + - + 
β-glucosidase + - - - - 
β-glucoronidase  + - - - - 
Nitrate reduction + - + - + 
Pyrazinamidase  + - + - + 
Esculin  + - - - - 
Gelatine (hydrolysis) + - - - - 
 
 Chemotaxonomy  
Both strains contained meso-diaminopimelic acid, arabinose and galactose in whole-
organism hydrolysates and strain Q2 contained glucose and ribose as well. The 
predominant isoprenologue in Q1 was tetrahydrogenated menaquinone with nine 
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isoprene units MK-9(H4) and for Q2 was tetrahydrogenated menaquinone with eight 
isoprene units MK-8(H4) (Figure S8). The polar lipid composition in Q1 was identified 
as diphosphatidyl-glycerol (DPG), phosphatidyl-N-methyl-ethanolamin (PME), 
phosphatidylethanolamine (PE) and phosphatidylglycerol (PG). For Q2 also DPG, PE, 
PG and phosphatidylcholin (PC) were identified (Figure S9). The major cellular fatty 
acids pattern of Q1 and Q2 consisted mainly of iso-C16:0 (40% and 42% respectively) 
and in this regard Q1 was similar to two type strains of A. rifamycinica DSM 46095 
and A. balhimycina DSM 44591 (Table 3-7) and strain Q2 had higher similarity to P. 
cypriaca DSM 45511 and P. hierapolitana DSM 45671. The major fatty acids of strain 
Q1 and Q2 and their type strains are shown in Table 3-6 and  
Table 3-7.  
Table 3-6 Cellular fatty acid composition of strain Q1 













saturated straight chain 
C14:0 0.91       
C15:0 2.52 2.17 1.63     
C16:0 8.27 7.91 7.67 5.64 6.83 4.82 3.04 
C17:0 2.68 6.14 4.29     
C18:0 1.85  2.6     
C21:0 2.68       
saturated branched chain 
iso- C14:0 4.78 1.63 2.23 2.29 3.08 2.17 1.85 
iso- C15:0 11 7.67 27.84 26.82 31.42 38.03 9.39 
iso- C16:0 40.5 40.82 27.11 14.58 16.3 7.5 39.33 
iso- C17:0 1.53 2.27 5.98 6.28 6.39 6.45 3.89 
anteiso- C15:0  1.53 2.6 31.13 23.27 32.19  
anteiso- C17:0 0.99 6.18 5.25 13.25 9.91 8.85 3.61 
cy C17:0 3.6       
C17:0 10- methyl  1.59     1.9 
iso- C18:0 0.83       
unsaturated chain 
C16:1ꙍ7 6.6 5.56 9.24    7.16 
C17:1ꙍ8 0.83 2.31     2.23 
C17:1ꙍ6 9.63 10.42 3.56    15.94 
iso- C16:1ꙍ6       5.31 
iso- C17:1ꙍ7  2.17   2.79  2.85 
iso- c/t C17:1ꙍ7       3.51 
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c/t C18:1ꙍ7 0.78       
C18:1ꙍ5  1.63      
 
Table 3-7 Cellular fatty acid composition of strain Q2 
Fatty acid Q2 DSM45511 DSM45671 DSM44774 DSM45352 
saturated straight chain 
C13:0     0.3     
C14:0     0.79     
C15:0 1.84 1.21 6.76 2.01   
C16:0 5.64 6.72 7.34 3.49 7.22 
C17:0 2.27 2.61 6.39 2.39   
C18:0         1.12 
saturated branched chain 
C14:0 3- hydroxy 1.04 0.69 0.49     
iso- C14:0 1.77 0.69 2.6 2.46 1.67 
iso- C15:0 8.29 5.81 8.01 5.87 38.35 
iso- C16:0 42.48 33.01 36.6 51.8 6.83 
iso- C17:0 3.36 4.95 2.54 6.44 7.55 
anteiso- C15:0 1.86 1.4 2.92 1.33 23.8 
anteiso- C17:0 9.6 14.2 9.56 5.84 8.01 
C17:0 10- methyl 4.48 4.19 2.74 6.4   
iso- C18:0 0.6  0.29     
unsaturated chain 
C15:1ꙍ6 0.51   1     
C16:1ꙍ5       2.73  
C16:1ꙍ7 1.61 5.49 1.79     
C17:1ꙍ8 2.77 5 5.27 2.05   
C17:1ꙍ6 1.26 2.17 1.05     
iso- C16:1ꙍ6 1.92 2.24 1.29 1.25   
iso- C16:1ꙍ8       2.01   
iso- C17:1ꙍ7 1.28 8.37 1.86 3.94   
iso- c/t C17:1ꙍ7 6.91 1.26 0.39     
C18:1ꙍ9         2.63 





 Secondary metabolites 
Both strains had weak activity against Gram-positive bacteria. The crude extracts 
derived from Q2 in 4 metabolite media (5254, 5294, soy meal, 5333) were analysed 
using high‐resolution electrospray ionization‐mass spectrometry (HR‐ESI‐MS). The 
main peak with the retention time (tR)=11 min, which was correlated to activity in the 
HPLC chromatogram showed ion at a mass‐to‐charge ratio (m/z) of 394.06 
corresponding to (M+H)+. There were 10 hits in the Dictionary of Natural Products, 
mostly belonging to the class of terpenoids like capparisesterpenolide A. No hits were 
found from the phylum Actinobacteria. The raw extract of Q1 showed a mass with 
specific UV absorption of 212, 255, 275, 335 nm with ion m/z 772.66 corresponding to 
(M+H)+. No hits were found in the DNP. 
3.1.1.2 44ZA and BA 
 Ecology 
among different soil samples, the soil of Semnan desert was chosen to isolate just non-
Streptomyces group of Actinobacteria (rare Actinobacteria). The soil was treated with 
different methods of pretreatment like adding chloramine T or heating the soil up to 60 
˚C for 30 minutes and using different and specific media for isolation. The list of rare 
Actinobacteria isolated after pretreatment are shown in Table 3-8. Two strains 44ZA 
and BA, were chosen for polyphasic taxonomy.  
Table 3-8 List of rare Actinobacteria isolated from Isfahan soil after treatment 
Isfahan 
NS38 Desert soil Nonomuraea harbinensis 99.62 
NS44 Desert soil Herbidospora sakaeratensis 97.64 
NS45 Desert soil Micromonospora echinofusca 99.63 
44ZA Desert soil Sanguibacter keddieii 98.34 
BA Desert soil Agromyces arachidis 99.08 
441B Desert soil Goordonia alkanivomans 100 
Sef Desert soil Prauserella alba 100 
SO Desert soil Dietzia maris 99.7 
44MX Desert soil Jonesia  quighaiensis 100 
44Z Desert soil Micrococcus aloverae 100 
 
The different morphology of isolated rare Actinobacteria in two media was shown in 
Figure 3-5. For instance, four isolates NS38 (Nonomuraea), 441B (Goordonia), 44MX 
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(Jonesia) and 44ZA (Micrococcus) showed quiet similar colonies with colors ranged 
from white to yellow in 5336 medium, which was different from GYM medium. On 
GYM medium, the colonies of NS38 (Nonomuraea), 441B (Goordonia) were orange 
and soft, formed bright orange color. For 44MX (Jonesia) and 44ZA (Micrococcus) on 
GYM medium, the colonies were bright yellow and soft. 
                      
                  
                       
Figure 3-5 Different morphologies of four isolates NS38 (Nonomuraea), 441B (Goordonia), 44MX 






based on the complete 16S rRNA gene sequencing, NS44ZA was found to be closely 
related to the type strain Sanguibacter keddieii with similarity of 98.34 %. The strain 
BA was closely related to Agromyces arachidis with 99.08 % and Agromyces indicus 
with similarity of 98.80 %. The type strain A. arachidis is not validly published, 
therefore, the analyses were done with the type strain A. indicus, which was close to A. 
arachidis (Table 3-9). 





Similarity based on 
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Whole-genome sequencing was performed using Illumina MiSeq (PE300) platform for 
both strains by Genomanalytik (GMAK) at HZI. The draft genome of NS44ZA 
consisted of 37 contigs with a total consensus of 3,475,186 bp and an average G+C 
content of 72.08 %. The digital DNA-DNA hybridization (dDDH) value between 
NS44ZA and S. keddieii was 22.2 %, which was below the threshold 70 %. Average 
nucleotide identity value was ˂90 % (77 %), which was below the threshold 94-96 %. 
The maximum-likelihood phylogenetic tree of NS44ZA revealed a higher similarity of 
the strain to two type strains: S. keddieii and S. inulinus (Figure 3-6).  
The whole-genome sequence of BA consisted of 88 contigs with a total size of 
3,870,556 bp and an average G+C content of 71.53 %. The phylogenetic tree was 
performed using the TYGS server. The results revealed that no specific type strain was 





Figure 3-6 Maximum-likelihood phylogenetic tree based on full-length 16S rRNA gene sequence 
of NS44ZA. Numbers above the branches are bootstrap support values greater than 60% for 
maximum-likelihood (left) and maximum-parsimony (right) method. Bar, 0.006. 
 
Figure 3-7 Maximum-likelihood phylogenetic tree based on full-length 16S rRNA gene sequence 
of BA. Numbers above the branches are bootstrap support values greater than 60% for maximum-
likelihood (left) and maximum-parsimony (right) method. Bar, 0.006. 
 Phenotype 
 Physiology 
Both strains grew well at different pH and temperatures up to 40 °C (Figure 3-8). They 
both had NaCl tolerance up to 5%. The ability to utilise different carbon sources in 
NS44ZA and its type strain S. keddieii, were different for two carbohydrates. Raffinose 
and inositol were used by S. keddieii but not NS44ZA. In contrast, strain NS44ZA 
showed better growth with rhamnose as carbone source (Figure S10). Strain BA utilised 
all carbon sources except cellulose (Figure S11). BA showed better growth than the 





Figure 3-8 Optimum temperature and pH for strains A) NS44ZA and B) BA 
 Morphology 
Colonies of both strains were smooth and convex. NS44ZA showed good growth on 
GYM, ISP 2, 4 and 5 but sparse growth in ISP 3 and 7. BA grew well on GYM but 
weak growth on ISP 2-7. No soluble pigments were seen in both strains (Figure 3-9). 
Figure 3-9 ISP and SSM plates of strains A) NS44ZA and B) BA 
 (left) A)GYM, B)ISP2, C)ISP3, D)ISP4, E)ISP5, F)ISP7 (right) A)ISP6, B)ISP7, C)SSM+, D)SSM- 
  
  








Enyzme activity in strains NS44ZA and S. keddieii were mostly similar, the differences 
were observed in α-mannosidase and ß-glucosamidase that were active in S. keddieii 
and not in NS44ZA and the ability of NS44ZA in hydrolysing gelatin and reducing 
nitrate (Figure 3-10). There were no significant differences between BA and A.indicus. 
α-galactosidase was quite strong in A.indicus and was not produced by BA. The 
opposite result was in ß-galactosidase. Pyrazinamidase and esculin (ß-glucosidase) 
activity were stronger in A.indicus (Figure 3-11). 
 
Figure 3-10 Enzyme activity of NS44ZA and S. keddieii 
 
 
Figure 3-11 Enzyme activity of BA and A.indicus 
 
 Chemotaxonomy 
 The cell-wall of NS44ZA contained MK-9(H4) as major menaquinone and leucine, 
alanine, glutamic acid and lysine as amino acids. Galactose, rhamnose and ribose were 
detected as cell wall sugars. In both NS44ZA and S. keddieii diphosphatidylglycerol 
(DPG) and phosphatidylinositol-mannoside (PIM) were found as main polar lipids. In 
NS44ZA phosphatidylglycerol (PG), three unknown phospholipids, three unknown 
lipids and one unknown glycolipid were detected. The detected sugars in BA cell-wall 
were galactose, glucose and ribose. However, the detected sugars in A.indicus were 
galactose and xylose. The cell wall diagnostic amino acid was 2,4-diaminobutyric acid. 
Diphosphatidylglycerol (DPG) and phosphatidylglycerol (PG) were found to be the 
main phospholipids. One unknown glycolipid and one unknown lipid were also 
detected in BA (Figure 3-23). The major fatty acids in strain NS44ZA consisted of 
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anteiso-C15:0 (50%), iso-C16:0 (16%) and C16:0 (15%), which were different from 
type strain S. keddieii. In S. keddieii, the main fatty acids were C16:0 (53%) and anteiso-
C15:0 (11%). The major fatty acids in strain BA were anteiso-C15:0 (39%), anteiso-
C17:0 (32%) and C16:0 (20%). In A.indicus C16:0 (38%) was the main fatty acid and 
after that anteiso-C15:0 (28%) and anteiso-C17:0 (22%). The differences in fatty acids 
are shown in Table 3-10.  
Table 3-10 Cellular fatty acid composition of strains NS44ZA, BA and their type strains 
Fatty acid BA DSM 26681 NS44ZA DSM 10542 
    A. indicus   S. keddieii 
saturated straight chain 
C14:0     6.1 5.8 
C15:0     1.51 0.5 
C16:0 2.56   15.01 53.3 
C17:0       0.5 
Saturated branched 
iso-C14:0 1.76 1.95 2.9 1.1 
iso-C15:0 3.32 6.29 0.99 3.2 
iso-C16:0 20.72 38.02 16.24 5.4 
iso-C17:0   2.09     
anteiso-
C15:0 
39.63 28.76 50.76 11.4 
anteiso-
C17:0 
32.01 22.89 6.5 2.4 
 
3.1.1.3 4NS15 Kibdelosporangium persicum 
 Ecology 
Isolate 4NS15 was isolated from a desert located in the city Kerman, Iran. 
 Genotype  
The strain showed 16S rRNA gene sequence similarity values of 98.9 % with the type 
strains of Kibdelosporangium aridum subsp. aridum, Kibdelosporangium 
phytohabitans, Kibdelosporangium philippinense and 98.6 % with the type strain 
Kibdelosporangium aridum subsp. largum, respectively (Table 3-11). Based on TYGS 
server phylogenetic tree, strain 4NS15 with NCBI accession number MN94780 had 
higher similarity to Kibdelosporangium metalli and philippiense (Figure 3-12). 
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K.aridum subsp. aridum 98.9 % DSM 43828 
K.aridum subsp. largum 98.6 % DSM 44150 
K.philippinense 98.6 % DSM 44226 
k.phytohabitans 98.6 % DSM 104448 
 
Whole-genome sequencing was achieved using PacBio-sequencing by GMAK, 
braunschweig. The data analysis was done by Dr. Nestor Zaburannyi in HIPS. The 
whole-genome shotgun project was deposited at DDBJ/ENA/GenBank under the 
accession JAAATY000000000. Isolate 4NS15 had a genome size of 10.35 Mbp with a 
G+C content of 68.1 mol %. Whole-genome phylogeny was generated using the TYGS 
server (Figure 3-13). The dDDH value between strain 4NS15 and its closest relative K. 
aridum was 29.8% (formula d4). The calculated difference of the GC content between 




Figure 3-12 Maximum-likelihood phylogenetic tree based on full-length 16S rRNA gene sequence  
of 4NS15 Numbers above the branches are bootstrap support values greater than 60% for  




Figure 3-13 Whole-genome sequence tree generated with the TYGS web server for strain 4NS15 
and closely related species 
 
MALDI-TOF analysis was done in DSMZ and the results confirmed that K. aridum 
subsp. aridum and K. aridum subsp. largum had the highest similarity to the strain 
4NS15 (Figure S14). 
 Phenotype 
 Physiology 
Optimal growth was observed on GYM at a temperature of 35 °C, pH 7.5 and in 
presence of NaCl concentration up to 2.5% (w/v). D-arabinose, xylose, rhamnose and 
mannose were utilised as sole carbon sources, whereas D-raffinose and cellulose were 
not used as a carbon source (Figure 3-14). 




   
Figure 3-14 Results of temperature, pH, salt and carbon utilisation of strain 4NS15     
 Morphology  
Scanning electron microscopy of strain 4NS15 from ISP2 medium after 10 days showed 
branched substrate mycelium, without sporangium-like (pseudosporangia) structures 
(Figure 3-15). The black red substrate mycelium and oxide red (3007) diffusible 
pigments were produced on GYM, ISP2 and ISP7 (Figure S15). 
 
Figure 3-15 Strain 4NS15 on Gym plates (up), Scanning electron micrographs (down). a) scale 10 
µm, b) scale 2 µm 
 Biochemistry 
Strain 4NS15 possessed substantial enzymatic activities for β-galactosidase, α-
glucosidase and gelatin liquefaction but no urease activity. Esculin and nitrate reduction 
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were negative (Figure S16). Differences in API ZYM and API Coryne are shown in 
Table 3-12. 












phosphohydrolase + - + + 
β-Galactosidase + + + - 
α-Glucosidase + - + + 
N-acetyl-β-
Glucosaminidase - + + + 
α-Mannosidase - + + + 
Pyrrolidonyl arylamidase + + + - 
Urease - + + + 
Note: + Positive or present; - negative or absent. All the data were obtained from this study under 
identical growth conditions 
 Chemotaxonomy 
The cell wall contained meso-diaminopimelic acid and the whole-cell sugars were 
arabinose, galactose, glucose and ribose. The quinone pattern consisted of major MK-
9(H4) and minor amounts of MK-9(H2). The phospholipid profile contained 
diphosphatidylglycerol (DPG), phosphatidylethanolamine (PE), 
phosphatidylhydroxyethanolamine (PE-OH), aminolipid and glycoaminolipid (Figure 
S17). Major cellular fatty acids pattern of 4NS15 consisted of C16:0 (25%), iso-C16:0 
(25%) and iso-C15:0 (16%), which was similar to type strain K.aridum. The differences 
between strain 4NS15 fatty acid pattern and other type strains are shown in Table 3-13.  
Table 3-13 Cellular fatty acid pattern of the strain 4NS15 and related species 
Fatty acid 4NS15 DSM 43828T DSM 44226 T DSM 104448 T 
    K.aridum K.philippinense K.phytohabitans 
saturated straight chain 
C14:0 1.4 2.2 2.9 3 
C15:0 3.2 0.6     
C16:0 25.6 8.9 4.4 4.7 
C17:0 6.6 0.5     




iso-C14:0   2.8 1.6 1.8 
iso-C15:0 16.8 12.7 16.1 11.3 
iso-C16:0 25 22.8 13.3 19.9 
iso-C17:0   2.1 1.4 2 
anteiso-C15:0 8.4 6.7 5.4 2.4 
anteiso-C17:0 7.1 9.9 4.7 4.2 
cy  C17:0     0.7 1.2 
iso-C18:0   0.4     
Unsaturated 
c/t C16:1ꙍ7   4.5 16.5 16.3 
iso-C16:1ꙍ8   0.7 0.9 7.7 
iso-C17:1ꙍ8C 1.8 5.2 10.3 0.3 
C17:1ꙍ6C   5.3 8.4 12.6 
C18:1ꙍ5   3 3.3 2.5 
 
 Fermentation and compound isolation 
4NS15 had high activity against M. luteus, S. aureus, E. coli TolC and poor activity 
against M. hiemalis and M. smegmatis. RP-HPLC fractionation coupled to HR‐ESI‐MS 
of the extracts showed five compounds with 14 units difference in the active area of 
strain 4NS15 chromatogram (Figure 3-16).  
 
 
Figure 3-16 High‐resolution electrospray ionization‐mass spectrometry (HR‐ESI‐MS) total ion 
current (TIC) of the 4NS15 crude extract with five peaks correlated to antibacterial activity 
 
The best medium, volume and day of harvesting were optimized. 10L of 5294 
metabolite medium were harvested after 13 days (2L flasks with 1L of metabolite 
medium). The pellet and supernatant were separated. 5% XAD were added to the 
supernatant and left shaking for 24 hours. The XAD resin from the supernatant was 
collected by sieving, washed by flushing with distilled water and then extracted three 
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times with methanol. 843 gram of cell pellet were extracted with acetone. Acetone was 
added to cell pellet, sonicated, filtered and the extract was evaporated in a rotary 
evaporator. After HR-ESI-MS analysis of 4NS15, the five targeted compounds were 
selected for isolation. 20 µl aliquots of the extracts were injected onto an analytical size 
luna5µm C18(250×4.6 mm) fitted with a guard-column. The compounds were 
separated by multi gradient elution using water with 0.1% formic acid as solvent A and 
acetonitrile with 0.1% formic acid as solvent B at a flow rate of 1 ml/minute. The 
optimal gradient determined was from 5 to 41% solvent B in 17 minutes, from 41% to 
61% of B in 20 min and from 61% to 95% of B in 2 minutes with a 6- minute hold at 
95% to clean the column. MS2 patterns have revealed that the compounds belong to one 
family. Among five compounds, fraction 3 (16.5mg) with ion m/z 813.53 corresponding 
to (M+H)+ was isolated and purified (Table 3-14). Structural elucidation was started by 
Dr. Emilia Oueis in HIPS and currently it is undergoing by Dr. Lena Keller in HIPS. 
Table 3-14 Isolated compounds and their weight 
Fraction Molecular weight Pure compound weight 
1 785.49 1.19 mg 
2 799.51 13.3 mg 
3 813.53 16.5 mg 
4 827.54 3.4 mg 
5 841.58 1.14 mg 
 
The pure compound of fraction 3 inhibited the growth of A549 and MCF-7 cell lines 
with the IC50 0.85 and 0.5 ng/ml respectively. Inhibition of the pure isolated compound 
on 8 cell lines were shown in Table 3-15. 
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Table 3-15 Cytotoxic assay ng/ml 
 
3.1.1.4 Ongoing projects 
Four strains NS40, NS37, NS25 and NS59 were chosen based on their taxonomy 
classification for additional analysis. All showed some antibacterial activity and beside 
polyphasic taxonomy, their crude extracts were screened for producing secondary 
metabolites.  
NS25 and NS59 
 Ecology 
NS59 isolated from Isfahan desert soil and NS25 isolated from beach sand in Qeshm 
island. 
 Genotype 
16S rRNA gene sequencing results of strain NS59 showed 98% similarity to 
Streptomyces specialis DSM 41924 although from morphological aspects, they were 
not similar. The phylogenetic tree generated using GGDC showed NS59 with low 
likelihood is similar to Streptomyces avicenniae and Streptomyces hainanensis (Figure 
3-17). NS25 showed 99.37% 16S rRNA gene sequencing similarity to strain 
Actinomadura deserti. Based on 16S rRNA gene sequences phylogenetic tree, NS25 
showed higher similarity to Actinomadura rifamycini (Figure 3-18). 
 
 
Figure 3-17 Maximum-likelihood phylogenetic tree based on full-length 16S rRNA gene sequence 
of NS59. Numbers above the branches are bootstrap support values greater than 60% for 





Figure 3-18 Maximum-likelihood phylogenetic tree based on full-length 16S rRNA gene sequence 
of NS25. Numbers above the branches are bootstrap support values greater than 60% for 
maximum-likelihood (left) and maximum-parsimony (right) method. Bar, 0.003. 
 Phenotype 
 Physiology  
The physiological characterization was investigated just for strain NS59. The optimum 
growth was observed at 35 °C in absence of salt. The carbohydrate utilisation was 
observed sparsely in all carbon sources (Figure S18). 
 Morphology 
Both strains grew slowly on 5336 and GYM plates. The colonies showed different 
morphology compared to the most similar type strains that are shown in Figure 3-19. 
The colonies of NS59 appeared after 10 days and grew sparsely on ISP plates. No 
pigment formation was observed in ISP plates for both strains (Figure S19). 
 
Figure 3-19 The comparison between two strains NS59 and NS25 with the most similar type strains 
 (A= NS59 on GYM plates; B= Streptomyces specialis; C= NS25; D= Actinomadura deserti; the 
pictures B and D were taken from DSMZ catalogue of microorganisms)  
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 Screening for secondary metabolites  
NS59 showed strong activity against Gram-positive bacteria and moderate activity 
against fungi. NS25 showed high activity against Staphylococcus aureus Newman and 
Bacillus subtilis DSM 10T and good activity against Gram-negative bacteria like E.coli 
TolC. The micro‐fractionation was performed in 96‐well plates to target the active 
compounds of the crude extracts of both strains. The HPLC fractionation experiments 
resulted in four fractions that inhibited the growth of S. aureus Newman in the strain 
NS25. Later the crude extract analysed using HR-ESI-MS and a family of compounds 
detected with the main protonated ion m/z 254.06 (M+H)+. The UV/Vis spectrum shows 
absorption maxima at 248 and 302 nm (Figure S20). The mass spectra of crude extract 
of the strain NS59 in retention time 14.5-25 minutes showed ion at m/z 251.20 (M+H)+. 
The UV/Vis spectrum showed absorption maxima at 268 nm (Figure S21). 
 
NS40 and NS37 
 Ecology  
Isolate NS40 was isolated from the soil around the root of plant Astragalus in the city 
of Yasooj and NS37 isolated from the sand in Boushehr, Iran.  
 Genotype  
The strain NS40 showed 16S rRNA gene sequence similarity values of 98.55% with 
three type strains of Streptomyces badius, Streptomyces sindenensis, Streptomyces 
parvus. Although in phylogenetic tree conducted from 16S rRNA gene sequencing, 
these three type strains classify in different clade but they were used for comparison in 
polyphasic taxonomy based on the EzTaxon database (Table 3-16)(Figure 3-20).  
Strain NS37 showed 99.58% similarity to Nocardiopsis umidischolae DSM 44362 and 
99.38% to Nocardiopsis tropica DSM 44381. According to phylogenetic tree analysis, 















          NS40 
CIP 111700 
 
Streptomyces badius 98.55% DSM 40139 
Streptomyces sindenensis 98.55% DSM 40255 
Streptomyces parvus 98.55% DSM 40348 
          NS37 
CIP 111703 
 
Nocardiopsis umidischolae  99.58% DSM 44362 






Figure 3-20 Maximum-likelihood phylogenetic tree based on full-length 16S rRNA gene sequence 
of NS40. Numbers above the branches are bootstrap support values greater than 60% for 
maximum-likelihood (left) and maximum-parsimony (right) method. Bar, 0.009. 
 
Figure 3-21 Maximum-likelihood phylogenetic tree based on full-length 16S rRNA gene sequence 
of NS37. Numbers above the branches are bootstrap support values greater than 60% for 
maximum-likelihood (left) and maximum-parsimony (right) method. Bar, 0.005. 
 
The DNA of both strains and the closest type strains (Table 3-16) were sent to 
Dr.Kämpfer for DDH analysis. The results were 25% between the strain NS40 and 
S.badius and 65.4% between NS37 and N.umidischolae, that was lower than the 
threshold value (70%) for identification of new species. The MLST analysis were 
conducted for both strains with three house keeping genes (trpB, gyrB and atpD). Strain 
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NS40 was found in a different clade based on 16S rRNA gene sequencing and from 
MLSA results (Figure 3-22). 
 
Figure 3-22 Maximum-likelihood and parsimony tree of strain NS40 and close type strains based 
on partial sequences of the three house-keeping genes gyrB, trpB and atpD 
 
Based on 16S rRNA gene sequencing, strain NS37 was closely related to N. tropica 
DSM 44381T rather than N. umidischolae DSM 44632T. The MLSA results showed that 
for gyrB gene, NS37 had higher similarity to Nocardiopsis alba (the sequences obtained 
from NCBI). The phylogenetic tree of trpB gene sequencing showed that NS37 shared 
same clade with N. umidischolae. The MLSA database lack sequences for atpD from 
Nocardiopsis, for that reason, Streptomyces MM98 was used in atpD phylogenetic tree 





Figure 3-23 Maximum-likelihood and parsimony tree of strain NS37 and close type strains based 
on partial sequences of the three house-keeping genes gyrB, trpB and atpD. 
 
The MALDI-TOF dendrogram indicated that strain NS37 is similar to N. umidischolae 
with no distance level (Figure S22). 
 Phenotype 
 Physiology  
The NaCl concentration that the strain NS40 could tolerate was 5% and for the strain 
NS37 was up to 10% (w/v). D-raffinose, cellulose and inositol were not used as a carbon 
source in NS40. NS37 could utilise different carbon sources except inositol and 
cellulose (Figure S23). 
 Morphology 
Scanning electron microscopy of strain NS40 from ISP3 medium after 10 days showed 
long aerial mycelium with spores and NS37 has broadly branched mycelium with 






Figure 3-24 Scanning electron micrographs. A) Strain NS40, scale 2 µm, B) Strain NS37, scale 2 
µm 
Strain NS40 grew well in all ISP media and no pigment formation was observed for the 
isolate. It had higher similarity to DSM 40139T, compared to other type strains, which 
formed white substrate mycelium (Figure S24). Strain NS37 had good growth in all ISP 
media and no pigment formation was observed for the strain. While DSM44381T 
formed red soluble pigment (Figure S25). 
 Biochemistry  
Many enzymatic activities were similar in the strain NS40 and its type strains. Some 
differences observed in α-chymotrypsin. The isolate NS40 showed less activity for 
chymotrypsin, compare to the other type strains. Strain NS40 possessed substantial 
enzymatic activities for N-acetyl-β-glucosaminidase. Nitrate reduction in NS40 and 






NS37 shared same enzyme activities with the other two type strains, except the activity 




Figure 3-25 Enzyme activity of strain NS37 and related type strains 
 Antibacterial assay of NS40 
The results of MIC showed that strain NS40 had strong antifungal activity. After media 
optimization, the metabolite medium 5294 was chosen for fermentation. The strain 
cultured in 50 flasks containing 100 ml of medium 5294 in 250 ml Erlenmeyer shaking 
for 7 days at 28 °C. After micro-fractionation of its crude extract using HPLC and later 
analysing HR-ESI-MS results, the data showed multiple compounds with ions m/z 
926.5, 910.5, 896.5 and 880.5 corresponding to (M+H)+. The UV/Vis spectrum showed 
absorption maxima at 222, 320, 336 and 352 nm (Figure S27).  
A search in the Dictionary of Natural Products (DNP), revealed that the protonated ion 
m/z 925.503504 (M+H)+ matched with the known compound, Amphotericin A with the 
molecular formula C47H75NO17. Amphotericin A produced by Streptomyces nodosus 
and known as antifungal agent (114). Some analytical scale optimizations for the 
separation of the mixture were unsuccessful and the project halted. 
 Antiviral assay of NS37 
The crude extract of strain NS37 that was harvested after 7 days from medium 5294 
and sent to TWINCORE for antiviral assay. The results revealed that the strain had 
strong antiviral activity (3-20% infectivity) against hepatitis C virus (HCV). Further 




Thirty-two myxobacteria were isolated from different locations in six cities of Iran and 
from the city Braunschweig in Germany. The list of all isolates with partial 16S rRNA 
sequence similarity are shown in Table 3-17.  






Similarity 16S rRNA 
(Partial %) 
Qeshm  NSX1,3,5,8,9,18 Sand 
Myxococcus 
xanthus 
99.57, 99.75, 99.57, 99.51, 
99.55, 99.58 
Yasooj NSX2,4,6,46 Soil 
Myxococcus 
xanthus 






99.65, 98.80, 100 




Isfahan NSX12,14,15,17 Soil 
Corallococcus 
exiguas 

























































Twenty-one strains of all Myxobacteria (66%) were characterized as members of the 
genus Myxococcus and 16% of isolates were characterized as members of the genus 
Corallococcus (Figure 3-26).  
 
Figure 3-26 Genus-level diversity of Myxobacteria isolated from soil samples 
All isolates were tested for antimicrobial activity and one strain (4NSX3) with the best 
activity against E. coli DSM 1611 was chosen for further investigation. 
3.1.2.1 4NSX3 
 Ecology  
Strain 4NSX3 was isolated from the desert soil Kerman, Iran. 
 Genotype  
Based on 16S rRNA gene sequencing similarity, it was 99.89 similar to Myxococcus 
xanthus. 
 Screening for secondary metabolites  
Strain 4NSX3 showed strong activity against E. coli TolC and E. coli DSM 1116. The 
crude extract was fractionated against E. coli DSM 1116 and the retention time of active 
zone was between 29.5 and 30.5 min. In HPLC results there was a small peak 
representing the active area, which appeared in HR-ESI-MS chromatogram as well 
(Figure S28). A search in Myxobase in-house database resulted in detection of the 








Myxococcus Corallococcus Hyalangium Nanocystis Sorangium Archangium
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3.2 Snail project 
From the collected snails during this study the total number of 28 Actinobacteria and 4 
Myxobacteria were isolated (Table 3-18). The isolated Actinobacteria belonged to 
different genera, including Streptomyces, Micromonospora, Nocardia, Kitasataspora 
and Nonomuraea (Figure 3-27). The isolated Myxobacteria belonged to the genus 
Myxococcus. 































Hanau NSMX Physa Myxococcus xanthus 100 








Darmstadt 3F1D Planorbis Streptomyces anulatus 100 










Rödermark 5NS2 Lymnaea Streptomyces omiyaensis 100 









5NS5 Lymnaea 99.53 
5NS6 Lymnaea Nocardia salmonicidae 100 
5NS7 Lymnaea Nocardia ignorata 99.69 
5NS11 Lymnaea Streptomyces paradoxus 99.88 
5NSX1 Lymnaea Myxococcus virescas 99.54 
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5NSX5 Potamopyrgus Myxococcus virescas 100 
7NS1 Physa Streptomyces violascens 99.75 
7NS3 Physa Streptomyces seoulensis 99.2 






















9NS4(3MO) Radix Nonomuraea fastidiosa 99.13 
9NSX(3WO) Radix Myxococcus xanthus 99.87 
9NS5 Planorbis Streptomyces yanii 100 
9NS6 Ancylus Streptomyces badius 100 
9NS7 Planorbis Streptomyces fulvissimus 100 
 
 
Figure 3-27 Genus-level diversity of isolated Actinobacteria from snail samples 
3.2.1 Microbial community of three freshwater snails 
To gain insight into the composition of the bacterial community (especially of the 





Streptomyces Micromonospora Nocardia Kitasataspora Nonumurae
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Lymnaea stagnalis and Physa acuta, a metagenome approach had been applied at the 
DSMZ, whereby amplicons of the V3 region of the 16S rRNA gene were analysed. 
DNA of the whole snails was extracted using the PowerSoil® DNA Isolation Kit and 
quantified using a nanodrop (Thermo Scientific). Amplicon sequencing of the V3 
region of the 16S rRNA gene yielded 340 Mbp of raw sequence data in the form of 
1,124,851 paired-end reads, with reads lengths of 2x151 bp. After amplicon analysis 
including: trimming, joining and removal of low-quality sequences, 894,391 full-length 
amplicons were obtained from, which 880,108 could be assigned to the bacterial 
domain by RDP Classifier. This part was done by Dr. Boyke Bunk and Dr. Katharina 
Huber.  
The results indicated that the predominant phyla in freshwater snails of Lymnaea 
baltica, Lymnaea stagnalis and Physa acuta, were Tenericutes, Firmicutes and 
Proteobacteria, respectively. The proportation of Actinobacteria and Myxobacteria 
were low in all snails (less than 2%) (Figure S29). From Lymnaea baltica and Lymnaea 
stagnalis, two Actinobacteria were isolated, which were close related to Streptomyces 
drozdowiczii and Streptomyces hydrogenous. From Physa acuta four Actinobacteria 
and one Myxobacterium were isolated.  Three of the Actinobacteria belonged to the 
genus Streptomyces and one belonged to the genus Micromonospora. The list of 
isolated strains and their similarity based on complete 16S rRNA gene sequencing are 
shown in Table 3-19. 
Table 3-19 List of isolated Actinobacteria and Myxobacteria from three freshwater snails 
 
 
Code Genus of snail 
Isolated Actinobacteria and 
Myxoacteria 
Similarity  16S 
rRNA (Partial) 
7NS1 Physa acuta Streptomyces violascens 99.75 
7NS3 Physa acuta Streptomyces seoulensis 99.2 
7NS5 Physa acuta Streptomyces speibonae 99.6 












Streptomyces drozdowiczii 99.77 
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3.2.1.1 Freshwater snail Physa acuta 
From the three mentioned freshwater snails, a Streptomyces (7NS3), which was isolated 
from Physa acuta was chosen for analysing the whole-genome sequence, screening for 
producing antibiotics and polyphasic taxonomy. The reasons of targeting this strain 
over the others, were having lower similarity in 16S rRNA gene sequencing and higher 
antimicrobial activity of its crude extract, compare to the other strains. 
3.2.1.2 Strain 7NS3 
 Ecology  
Isolate 7NS3 was isolated from freshwater snail Physa acuta, which was collected from 
a pond (52° 6’ 42.32” N, 10° 40’ 46.20” E) in Remlingen-Semmenstedt, Germany in 
June 2019 by Dr. Joachim Wink.  
 Genotype  
Based on complete 16S rRNA gene sequencing, 7NS3 showed the highest similarity of 
99.59% to Streptomyces seoulensis NRRL B-24310T in the EzTaxon database. 
Phylogenetic tree results using GGDC server were in line with 16S rRNA gene 




Figure 3-28 Maximum-likelihood phylogenetic tree based on full-length 16S rRNA gene sequence 
of 7NS3. Numbers above the branches are bootstrap support values greater than 60% for 
maximum-likelihood (left) and maximum-parsimony (right) method. Bar, 0.008. 
 
The draft genome sequence of 7NS3 was obtained using Illumina whole-genome 
sequencing performed in DSMZ. The genome was assembled to 49 quality-controlled 
contigs (> 450 bp) summing up to a total genome size of 6.85 Mbp with a GC content 
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of 71.6%. Digital DNA-DNA Hybridization (dDDH) of Streptomyces sp. 7NS3 and S. 
seoulensis NRRL B-24310T showed the value of 29.5%, which was below the threshold 
of 70%. 7NS3 represented a novel Streptomyces species, which was deposited as 
Streptomyces sp. NCCB100804 and DSM 110735. 
 Phenotype 
 Physiology  
Strain 7NS3 grew at pH 6,7 and 8 but the optimum growth was observed at pH 7. Strain 
7NS3 tolerated up to 5% NaCl and had the ability to utilise different carbon sources 
(Figure S30). 
 Morphology  
Scanning electron microscopy of strain 7NS3 from ISP3 medium after 10 days showed 
long-chain of spores with smooth surfaces (Figure 3-29). The gray substrate mycelium 
and aerial mycelium were observed in all ISP plates and they formed no pigments on 
melanin plates (Figure S31). 
 
Figure 3-29 Scanning electron micrographs, scale 2 µm 
 Biochemistry 
Strain 7NS3 possessed substantial enzymatic activities for alkaline phosphatase, 
leucine arylamidase, acid phosphatase and α-glucosidase. Esculin and nitrate reduction 





Figure 3-30 Enzyme activity of strain 7NS3 
 Chemotaxonomy 
The cell wall contains LL-diaminopimelic acid and the whole-cell sugars were 
mannose, glucose and ribose. The quinone pattern consisted of major MK-9(H4) and 
MK-9(H6). The present phospholipids were phosphatidyl-N-methylethanolamine 
(PME), diphosphatidylglycerol (DPG), glucosamine (GAL) and phosphatidylinositol 
(PI) (Figure S32). Major cellular fatty acids pattern of strain 7NS3 consisted of C15:0a 
(28.9%), C16:0i (21.6%) and C16:0 (9%).  
 Metabolite profiling  
The MIC results from the crude extract (1mg/ml) of strain 7NS3 had the highest activity 
against S. aureus (Newman) and B. subtilis DSM 10T with an MIC value of 8.3 µg/ml 
and 0.52 µg/ml, respectively. 
The 7NS3 crude extract was fractionated by HPLC to determine the peak‐related 
activities. The micro‐fractionation resulted in four fractions that inhibited the growth of 
B. subtilis DSM 10T and two fractions inhibiting S. aureus Newman. In order to identify 
the associated target masses of the detected active fractions, the crude extract was 
analysed using HR‐ESI‐MS. The four peaks, which were correlated to activity in the 
HPLC chromatogram, were detected in the HR‐ESI‐MS total ion current (TIC) and 
named compounds 1 to 4 (Figure S33). The mass spectra of compound 1 with the 
retention time (tR) = 10.39 min showed ions at a mass‐to‐charge ratio (m/z) of 289.0857, 
corresponding to (M+H)+. The UV/Vis absorption bands were located at 232 nm, 380 
nm and 458 nm. The second compound, with a chromatographic retention time of 10.49 
min, presented mass spectra with ions m/z 307.0966, m/z 329.0785 and m/z 289.0859 
corresponding to (M+H)+, (M+Na)+ and (MH+ − H2O), respectively. The third 
molecule, with tR= 11.49 min, showed ions m/z 309.1118, m/z 331.0939 and m/z 
291.1014 corresponding to (M+H)+, (M+Na)+ and (MH+ − H2O), respectively. The 
suggested formulas of C19H14O4 and C19H16O4 were obtained for compounds 3 and 4 
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by the SmartFormula™ algorithm in Compass software from Bruker. A search in the 
Dictionary of Natural Products (DNP) database revealed that the protonated ion m/z 
309.1118 (M+H)+ matched with the known compound, emycin A. Emycin A has a 
molecular weight of 308.3436 g mol−1 (m/z 309.3436 (M+H)+) and a formula of 
C19H16O4. The UV/Vis spectrum showed absorption maxima at 217 nm, 260 nm and 
402 nm. The characteristic UV/Vis absorption bands at 220 nm, 260 nm and 402 nm of 
compound 3 matched with those of emycin A. The chromatogram pattern of compounds 
1 and 2 indicated the structural isomers of the main compound. From the UV bands and 
mass similarity, it can be concluded that compound 3 has a double bond compared to 
compound 2. Compound 4 with a tR of 15.39 min presented a mass spectra with ions 
m/z 255.2319 and m/z 256.2635 corresponding to (M+H)+ that matched with 
hexadecenoic acid in the in‐house Myxobase database. This fatty acid with the 
molecular formula of C16H30O2 had antibacterial activity against Gram-positive 
bacteria. 
 BGC identification and antiSMASH output  
The genome sequence was analysed with the bioinformatic tool antiSMASH 5.0. A 
total of 12 BGCs were detected, whereby six of them matched known clusters for 
alkylresorcinol, scabichelin, informatipeptin, geosmin, albaflavenone and ectoine with 
100% similarity. One BGCs showed >80% similarity to a BGC encoding a potential 
spore pigment. Three BGCs showed >60% similarity to clusters encoding 
desferrioxamin, melanin and hopene. The remaining BGCs with similarities <50% were 
predicted to encode two nonribosomal peptides, one polyketide, one polyketide-
nonribosomal peptide hybrid, one thiopeptide, one siderophore, one lassopeptide, one 
terpene and one bacteriocin (Figure S34). The BGC identification and antiSMASH 
analysis were performed by Dr. Yvonne Mast. Based on antiSMASH analysis results, 
the strain 7NS3 harbored a potential angucycline-like BGC, which is suggested to code 
for the emycin A-like substance. To prove the functionality of the identified BGC and 








Identification of less than 1% of the existing microorganisms until date implies the 
presence of a large number of microorganisms in natural environments that are yet to 
be fully explored (81). Microbial natural products are promising sources for drug 
discovery, although access to new scaffolds with strong activity have become difficult 
over past few decades. That is mostly because of rediscovery issues, challenges of 
isolating new producers and low concentration of the producer’s secondary metabolites 
(115). Among prokaryotes, filamentous actinomycetes, the myxobacteria, the 
pseudomonads and cyanobacteria have the potential to produce many diverse 
metabolites (116). Soil as the most significant source of actinomycetes has been 
explored extensively across the globe. Previously this exploration resulted in discovery 
of many new antibiotics but recently, rediscovery of already known species and 
compounds, grew the interest towards under-investigated habitats (81). Deserts, 
mangrove forests, medicinal plants and symbiotic association (specifically freshwater 
snails) are chosen as unexplored habitats within the scope of this research. Although 
deserts account for 20% of the landmass on the planet, they have received little attention 
from microbiologists (61). The most studied desert in terms of isolating Actinobacteria 
is the Atacama Desert in Chile (61). The strains isolated from this well-known desert 
belong not only to the ubiquitous genus Streptomyces, but also to rare or scarcely 
studied genera like Actinomadura, Amycolatopsis, Nocardiopsis, Nonomuraea, 
Saccha- ropolyspora and Saccharothrix. The most culture-independent studies of arid 
areas show Actinobacteria as one of the three most abundant phyla and in case of the 
Atacama Desert, it is the most dominant phylum (72-88%) (117).  
4.1 Isolates from the desert 
In order to isolate Actinobacteria and Myxobacteria from the desert, we collected three 
samples from two deserts in Iran. Rige jen in the border of Semnan and Isfahan 
provinces and Shahdad in city Kerman were the locations for sands collection. The 
strategy applied for routine isolation process was using 5336 medium for 
Actinobacteria and water agar plus E.coli and ST21 for Myxobacteria isolation. 
However, for Isfahan sand samples other strategies of pretreatment were performed to 
isolate rare or non-Streptomyces. The pretreatments included heating the soil at 60 ˚C 
for 30 minutes, adding chloramine T, using humic acid-vitamin agar (HV), ISP4 and ISP2 
plates for the first step isolation. The research team lead by Hayakawa worked extensively 
79 
 
on developing different methods or various media combination in order to isolate 
uncommon or less studied Actinobacteria (118). Streptomyces is the largest and the most 
dominant genus in normal isolation methods. It is also important because of its ability in 
the production of the large number of natural antibiotics such as streptomycin, daptomycin, 
erythromycin, fosfomycin, lincomycin, neomycin and tetracycline (119). The normal 
isolation media including 5336 medium contain starch as carbon source and casein as 
nitrogen source that results in the good growth of Streptomyces. However, in this study as 
mentioned above, we tried to isolate non-Streptomyces genera by treating the sand sample. 
The rare actinomycetes or non-Streptomyces are usually regarded as strains of 
actinomycetes that are slow growing and difficult to isolate or culture. Currently, they have 
been known as highly prospective sources of bioactive compounds (119). HV agar, which 
was used as one of the pretreatment methods (containing soil humic acid as the sole carbon 
and nitrogen source), permit good growth of not only Streptomyces colonies, but also other 
actinomycetes belonging to genera Microbispora, Streptosporangium, Micromonospora 
and Dactylosporangium (84). The isolated bacteria from two untreated sands belonged to 
the genera of Streptomyces and Kribbella from Rige jen and Kibdelosporangium and 
Saccharothrix from Shahdad desert.  
4.1.1 Description of strain 4NS15 and its secondary metabolites 
Among isolates from untreated sands, the isolate 4NS15, which belonged to the genus 
Kibdelosporangium showed 16S rRNA gene sequence similarity values of 98.9 % to three 
type strains of Kibdelosporangium aridum subsp. aridum, Kibdelosporangium 
phytohabitans and Kibdelosporangium philippinense and 98.6 % to the type strain K.  
aridum subsp. largum. The genus Kibdelosporangium is considered as a rare genus, which 
belongs to the family Pseudonocardiaceae. Kibdelosporangium aridum subsp. aridum 
DSM 43828T is the type species and this taxon encompasses nine validly published species 
(66). Members of this genus grow aerobically and their cell-wall peptidoglycan contain 
meso-diaminopimelic acid. The whole-cell sugar pattern consists of arabinose, galactose 
and some traces of madurose (120). This genus is famous for forming sporangium-like 
structures (pseudosporangia), whereas isolate 4NS15 did not have this typical 
characteristic. In terms of genotype the strain has a genome size of 10.35 Mbp with a G+C 
content of 68.1 mol% and the dDDH value between strain 4NS15 and its closest relative 
K. aridum was 29.8%, which is below threshold of 70%. In phenotypic analysis, it 
showed more similarity to K.  aridum subsp. aridum. On the other hand, there are some 
significant differences in enzyme activity and the pigment formation of both strains. The 
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phospholipid profile of strain 4NS15 contains diphosphatidylglycerol, 
phosphatidylethanolamine, phosphatidylhydroxyethanolamine, aminolipid and 
glycoaminolipid. The predominant menaquinone is MK-9(H4) and major fatty acids (>10 
%) are C16:0, iso- C16:0 and iso- C15:0. In our recently published work, we have 
described the polyphasic taxonomic study of this strain (121). Based on its genotypic and 
phenotypic characteristics described in our work, the strain represents a novel species with 
the proposed name Kibdelosporangium persicum sp. nov. and has been deposited as NCCB 
100701=CIP 111705=DSM 110728. 
The genus Kibdelosporangium is known to produce novel antibiotics with 
glycopeptide, macrolides and polyketide structures (122). Aridicins A, B and C are 
three glycopeptide antibiotics produced by K. aridum subsp. aridum (123). Isolate 
4NS15 showed high activity against M. luteus, S. aureus, E. coli TolC and poor activity 
against M. hiemalis and M. smegmatis. After screening for its secondary metabolites, a 
family of compounds were identified that showed correlation to antibacterial activity. 
The structure elucidation of these potentially new compounds, which have been isolated 
are still being completed. 
The isolated bacteria from treated sand (dried, heated with chloramine T) and selected 
isolation plates (HV-agar, ISP2 and ISP4) from Isfahan desert, showed more diversity in 
taxonomy. The bacteria belonged to the different rare genera of Nonomuraea, 
Herbidospora, Micromonospora, Sanguibacter, Agromyces, Gordonia, Prauserella, 
Dietzia, Jonesia and Micrococcus. This study showed that with different culturing methods, 
we are able to isolate underexplored members of the phylum Actinobacteria that lead us to 
the discovery of new compounds and later antibiotics. 
Two isolates of the genera Sanguibacter and Agromyces were chosen from the treated sand 
of Isfahan desert for polyphasic taxonomy. 
4.1.2 Description of strains NS44ZA and BA  
The isolate NS44ZA was discovered as closely related to the type strain Sanguibacter 
keddieii with 16S rRNA gene sequencing similarity of 98.34 %. The genus Sanguibacter 
belongs to the family of Sanguibacteraceae and encompasses five validly published 
species by searching for LPSN (https://www.bacterio.net/). From genotype comparison, 
the digital DNA-DNA hybridization value between NS44ZA and S. keddieii was 22.2 
%, which was below the threshold of 70 %. The draft genome of NS44ZA consisted of 
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37 contigs with a total consensus of 3,475,186 bp and an average G+C content of 72.08 
%. Two strains were different in utilising different carbon sources. Raffinose and inositol 
were used by S. keddieii, whereas NS44ZA utilised rhamnose as carbon source. S. 
keddieii had an enzyme activity for α-mannosidase and ß-glucosamidase, whereas the 
strain NS44ZA had no activity for those enzymes but had activity for hydrolysing 
gelatin and reducing nitrate. The major fatty acids in strain NS44ZA consist of anteiso-
C15:0 (50%), iso-C16:0 (16%) and C16:0 (15%), whereas in S. keddieii, the main fatty 
acids are C16:0 (53%) and anteiso-C15:0 (11%). 
The isolate BA was closely related to Agromyces arachidis and Agromyces indicus with 
99.08 % and 98.80 % similarity based on complete 16S rRNA gene sequencing, 
respectively. Since, A.arachidis is not validly published, A.indicus was chosen for 
comparison in the polyphasic approach. The genus Agromyces belong to the family of 
Microbacteriaceae and encompasses thirty-six validly published species by searching for 
LPSN (https://www.bacterio.net/). The whole-genome of the strain BA consisted of 88 
contigs with a total size of 3,870,556 bp and an average G+C content of 71.53 %. 
Possessing light-induced pigments, 2,4-diaminobutyric acid (DAB) in the cell wall and a 
fragmented vegetative mycelium are the normal characteristic of many Agromyes species 
(120), which was also observed in the strain BA. One of the phenotypic differences of the 
strain BA with its type strain related to the enzyme activity of α-galactosidase that was 
quite strong in A.indicus (not in BA) and ß-galactosidase, which was active in the strain 
BA. The major fatty acids in strain BA were anteiso-C15:0 (39%), anteiso-C17:0 (32%) 
and C16:0 (20%), whereas in A.indicus, C16:0 (38%) was the main fatty acid followed 
by anteiso-C15:0 (28%) and anteiso-C17:0 (22%). Other characteristics were similar 
and typical for Agromyces. Based on phenotypic and genotypic characteristics, both 
strains represent novel species. 
4.1.3 Myxobacteria isolated from desert  
In this study, thirty-two Myxobacteria have been isolated from different soil samples 
including desert, mangrove forest and medicinal plants soil. Four Myxobacteria have 
been isolated from freshwater snails. 66% of them belonged to the genus Myxococcus. 
Unfortunately, there were no interesting taxonomical Myxobacteria among the isolates. 
All isolates were screened in terms of production of novel secondary metabolites. One 
isolate 4NSX3, which showed 99.89 % similarity to Myxococcus xanthus (based on the 
complete 16S rRNA gene sequencing) showed high activity against E.coli TolC and 
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E.coli DSM 1116. However, dereplication revealed that the activity correlated to the 
already known compound myxovirescin C. The chances of discovering novel 
metabolites in Myxobacteria would increase by taxonomic distance, meaning that novel 
metabolites are more likely to be obtained from new genera rather than additional 
representatives within the same genus (21). 
4.2 Isolates from mangrove forest and silver beach 
Qeshm Island is the largest island in the Persian Gulf with a surface area of 1,491 square 
kilometers of which about 67.5 km² of it are covered by mangrove forests (Hara 
forests). One of the soil samples was collected from the Hara mangrove forest. Hengam 
island is a small island (37 km²) located in south of Qeshm island that is famous for its 
silver sand on the beach, which is explained by the presence of silica and aminosilicate. 
There was also a sand sample collected from this silver beach. Mangrove forests are 
unique plant community in tropical coastal areas with the most productive ecosystems 
(124). Some metagenomics studies about microbial communities of mangrove forests 
showed that Proteobacteria, Firmicutes and Actinobacteria are the dominant phyla 
represented in mangrove area (124). Lee et al,. 2014, have described mangrove 
environment as a rich reservoir for novel genera and species like Mumia flava gen. nov., 
sp. nov. or Microbacterium mangrovi sp. nov. (125).  On the other hand, this study was 
a first trial aimed at isolating Actinobacteria from silver beach of the Hengam island. 
The isolated Actinobacteria from Hara mangrove forest and silver beach belonged to 
the genera of Streptomyces, Amycolatopsis, Pseudonocardia and Actinomadura. Two 
isolates of silver beach named Q1 and Q2 were chosen for polyphasic taxonomic 
characterization. 
4.2.1 Description of strains Q1 and Q2 
Two isolates Q1 and Q2 were found to be closely related to the type strains 
Amycolatopsis rifamycinica and Pseudonocardia cypriac with 99.03% and 99.65% 
similarity based on their 16S rRNA gene sequencing, respectively. Both genera belong 
to the family Pseudonocardiacea. Amycolatopsis encompasses 82 and Pseudonocardia 
61 validly published species by searching for LPSN (https://www.bacterio. net/). Some 
typical phenotypic characteristics were similar in all genera such as the aminoacid in their 
peptidoglycan (which is meso-diaminopimelic acid) and galactose as one of many 
diagnostic whole-cell sugars. The phospholipid profile included 
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phosphatidylethanolamine and menaquinones mostly contained nine isoprene units 
(120). Genotypic analysis of dDDH showed that Q1 was more related to the type strain 
Amycolatopsis saalfeldensis DSM 44993T with 29.0% accordance and Q2 had higher 
similarity to the type strain Pseudonocardia hierapolitana DSM 45671T with the value 
of 46.1% accordance. In both cases the values were below 70% (threshold). Because of 
the lack of genome sequences in public databases and low-quality of available genome 
sequences, obtaining the complete genomes for taxonomic purposes without the results 
of phenotypic and chemotaxonomic analysis would be impractical (34). Both isolates 
grew well on the plates with pH of 8,9 and 10, which was predictable, because the silver 
beach sand also had a pH of 8.49 without ion exchanger. Based on Bergey’s systematic 
bacteriology, the genus Amycolatopsis can produce aerial mycelium and the substrate 
mycelium fragments into irregular rods. In the genus Pseudonocardia vegetative 
mycelium can fragment and there is no spore chain produced on aerial mycelium (120). 
Both strains Q1 and Q2 produced no aerial mycelium and their substrate mycelium 
fragmented in rods under the light microscope. For chemotaxonomic analysis, the 
isolate Q1 was compared to six type strains: A. rifamycinica DSM 46095, A. 
rhabdoformis SB026, A. kentuckyensis DSM 44652, A. lexingtonensis DSM 44653, A. 
pretoriensis DSM 44654 and A. balhimycina DSM 44591. All type strains were 
cultured under the same culture conditions. Based on enzyme activities, the strain Q1 
showed more similarities to type strains A. rifamycinica and A. rhabdoformis, for 
example, possessing enzymes like α-fucosidase. Strain Q1 showed difference with all 
type strains for its β-glucoronidase activity. The predominant menaquinone and polar 
lipids were close to other type strains but the fatty acid pattern had more differences 
that were similar to A. rifamycinica. The isolate Q2 was compared in all analyses with 
four type strains: P. cypriaca DSM 45511, P. hierapolitana DSM 45671, P. zijingensis 
DSM 44774 and P. adelaidensis DSM 45352. For enzyme activity, it showed more 
similarity to the type strains of P. hierapolitana and P. adelaidensis especially for 
nitrate reduction and positive activity of pyrazinamidase. The strain Q2 was able to 
produce β-glucoronidase and β-glucosidase, which were not produced in other type 
strains. The most similar fatty acid pattern was observed in Q2 and P. cypriaca. 
From 2008 until 2018, rare actinomycetes including the genera Micromonospora, 
Actinomadura and Amycolatopsis attracted the attention of many researchers due to 
their potential in producing bioactive compounds (126). The genus Amycolatopsis 
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specifically is an interesting genus for the pharmaceutical industry. There are many 
important antibiotics produced by the members of this genus, such as rifamycin (127), 
vancomycin (128), balhimycin (129) and dethymicin (130,131). Strain Q1 showed 
antibacterial activity against Gram-positive bacteria and could be potentially a good 
candidate for further investigation on its secondary metabolites.  
Pseudonocardia is another interesting genus of rare Actinobacteria, which is known to 
produce novel bioactive compounds such as pseudonocardide A–G (132), branimycin 
B-C (133), pseudonocardian A–C (134). Strain Q2 showed activity against Gram-
positive bacteria and need further investigation for its bioactive compounds. 
4.3 Isolates from the soil of medicinal plants 
Iran has a rich flora and strong background in consuming medicinal plants for 
therapeutic usage (135). There are some local plants in non-popular cities of Iran where 
locals would know about their benefits. In order to screen associated Actinobaceria of 
these local plants, the soil samples from their root, their leaves and some wooden part 
of their stem were collected. The samples were collected from Almond, Mord (kind of 
myrtle), Khesht, Oak, Astragalus and Safran. The most abundant genera isolated from 
them were Streptomyces (16 different species), Lentzea (2 species) and Amycolatopsis 
(1 specie). Although in culture-dependent studies, the most of identified isolates 
belonged to the genus Streptomyces, but culture-independent studies using 16S rRNA 
gene amplicon sequencing, have shown that this genus formed a small portion of 
actinobacterial communities in different habitats like soil, plant or marine sediments 
(136). The genus Streptomyces provides half of all known actinobacterial compounds 
(137). Although, from 1985 there was a decline in discovery of new antibiotics from 
them but they continue to promising until date. Recently a new strain of Streptomyces 
sioyaensis, named Streptomyces sp. TM32 was isolated from the rhizosphere of 
Curcuma longa L., a medicinal plant, which was also used in cooking and has strong 
antimicrobial activities against both human and plant pathogens (138). Among all of 
the isolates from the medicinal plants collected from cities Yasooj and Tafresh, one 
isolate from Astragalus plant showed strong antifungal activity and low phylogenetic 




4.3.1 Strain NS40 and its secondary metabolites 
This strain NS40 showed the highest similarity to Streptomyces badius DSM 40139 by 
98.55% based on 16S rRNA gene sequencing. The result of DDH showed the value of 
25% between these two strains, which was below the threshold of 70%. Two other type 
strains were chosen for the polyphasic taxonomic approach (Streptomyces sindenensis 
and Streptomyces parvus). The phylogenetic results revealed that strain NS40 belonged 
to another clade that was not close enough to other three type strains, which were 
suggested by the EzTaxon server. The phenotypic analyses were in line with genotypic 
analyses and showed different enzyme activity and fatty acid patterns for the strain 
NS40. High-performance liquid chromatography (HPLC) and high-resolution 
electrospray ionization-mass spectrometry (HR-ESI-MS) analyses of crude extract 
fractions resulted in the detection of an already known compound, Amphotericin A. 
This antifungal compound was isolated from Streptomyces nodosus was collected from 
soil samples in Orinoco River region of Venezuela (114). Previously the anti-candidal 
activity of Astragalus verus was studied in guinea pig model for systematic candidiasis 
(139), but to the best of our knowledge there has been no study aimed to culture 
Astragalus-associated Actinobacteria. 
4.4 Isolates from freshwater snails 
Actinobacteria as a defensive symbiont has captured the attention of researchers for 
several decades. This interaction has been well-studied in some invertebrates including 
insects within Actinobacteria that protect the host or the food source by producing 
antibiotics (31). After insects, Mollusca is the second-largest phylum of the 
invertebrates and there exist only few studies on the most diverse group of them, 
gastropoda. Cone snails in marine habitats have been studied so far for the associated 
Actinobacteria and their secondary metabolites (140). The neuroactive thiazoline 
metabolites pulicatins A-E have been extracted from a novel Streptomyces sp. isolated 
from Cone snails (141). In this study, the diversity and antimicrobial potential of 
freshwater snails-associated Actinobacteria were assessed by culture-dependent and 
culture-independent approaches, respectively.  
4.4.1  Culture-dependent analyses 
Totally 28 Actinobacteria (including genera Streptomyces, Micromonospora, 
Nocardia, Kitasataspora and Nonomuraea) and 4 Myxobacteria (genus Myxococcus) 
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were isolated from different genera of freshwater snails that were collected from 
different regions of Iran and Germany. Among all of them, one isolate 7NS3 showed 
good antibacterial activity and low similarity 99.2% to Streptomyces seoulensis NRRL 
B-24310T. Therefore, it was chosen for polyphasic taxonomy and further investigation. 
4.4.2 Description of strain 7NS3 and its secondary metabolites 
Strain 7NS3 was isolated from the freshwater snail Physa acuta collected in 
Remlingen-Semmenstedt, Germany. Physa acuta has a widespread distribution across 
the world due to its rapid generation time and high productivity, which increase their 
population, it additionally acts as an intermediate host of some trematode diseases, such 
as echinostomiasis and fascioliasis (75). Although some other strains were isolated 
from this snail, the highest activity was observed for the crude extract of strain 7NS3, 
with an MIC value of 8.3 µg/ml and 0.52 µg/ml against S. aureus (Newman) and B. 
subtilis DSM 10T, respectively. The whole-genome sequence of isolate 7NS3 contained 
a total genome size of 6.85 Mbp with a GC content of 71.6% and the dDDH result of 
Streptomyces sp. 7NS3 and S. seoulensis NRRL B-24310T showed the value of 29.5%, 
which was below the threshold of 70%. The results of high-performance liquid 
chromatography (HPLC) and high-resolution electrospray ionization-mass 
spectrometry (HR-ESI-MS) analyses of crude extract fractions resulted in the detection 
of four compounds, one of which matched the compound characteristics of the emycin 
A, an angucycline-like aromatic polyketide. Genome mining studies based on the 
whole-genome sequence of 7NS3 resulted in the identification of a gene cluster 
potentially coding for emycin A biosynthesis. In our recently published work, we have 
described more details about this strain (142). 
4.4.3 Culture-independent analyses 
To obtain the composition of the bacterial community, especially of the phylum 
Actinobacteria, a metagenome approach was performed (142). The amplicon reads of 
the V3 region of the 16S rRNA gene grouped 21 phyla with the most abundant phyla 
Proteobacteria (65%), Bacteroidetes (17%), Cyanobacteria and Chloroplast (8%) and 
Firmicutes (6%). The phylum Actinobacteria encompasses just 2% of the bacterial 
population with the predominant family of Kineosporiaceae (26%), Microbacteriaceae 
(20%), Acidimicrobiaceae (18%) and Nocardioidaceae (10%). The family 
Streptomycetaceae represented just four identified sequences. Previously, there were 
some studies on microbial communities of freshwater snails, for example in Radix 
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auricularia, the predominant phyla were Proteobacteria (35%), Cyanobacteria (16%), 
Firmicutes (14%), Chloroflexi (9%) and Actinobacteria (8%) (143). Investigation into 
the intestinal bacterial community in planorbid snails revealed that 
Gammaproteobacteria, Bacteroidetes and Acidobacteria were the predominant phyla 
(144). Host diet, physical and chemical conditions of the intestine, age and many other 
factors could affect the indigenous gut microbial community (144,145). The other 
studies about microbiome of freshwater snails were mostly limited to exploring 
cellulolytic bacteria or determining the roles of gut bacteria in physiology and 
immunology of the host. Therefore, it is suggested not only to rely on culture-
independent studies but also to combine it with culture-dependent studies to make the 



















The aim of this work was to isolate new strains of two promising groups of bacteria in 
terms of producing novel bioactive compunds. Myxobacteria and Actinobacteria are 
two groups that we have focused on. The samples were collected from uncommon 
habitats of Iran. Some non-typical environments like the desert, mangrove forest, 
medicinal plants and the beach sand. On the other hand, investigating about freshwater 
snails was captured our attention. The bacterial diversity of freshwater snails was 
reported before but studies on culture-dependent approaches were limited.  
In the context of this work, no interesting Myxobacteria was isolated. However, there 
were quite interesting species of Actinobacteria that belonged to non-Streptomyces 
group. Among them 5 novel species were identified and characterized with whole-
genome sequencing and polyphasic taxonomy approach. The strains 4NS15, Q1, Q2, 
44NSZA, BA belonged to the genera Kibdelosporangium, Amycolatopsis, 
Pseudonocardia, Sanguibacter and Agromyces respectively. Besides, their interesting 
taxonomical features, their ability to produce active secondary metabolites were tested. 
The crude extract of strain 4NS15 showed strong bioactivity against Gram-positive 
bacteria and after fermentation of 20 Liter of its crude extract, a family of compounds 
belonged to the class of terpenoids were isolated and purified. The structure elucidation 
of this family is still undergoing. 
The other project on freshwater snail Physa acuta resulted in identifying a new species 
of the genus Streptomyces that its crude extract showed good activity against Gram-
positive bacteria and dereplication showed the activity came from an already known 
compound named Emycin A that can be isolated and purified in future. 
To conclude, it can be confirmed that the search for new natural substances in unexplored 
habitats is proving successful and different media and culture condition are needed to target 
taxonomical interesting strains. Furthermore, freshwater snails should consider as a 
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7  Appendix 
 
Table S1 List of all used media  
Isolation and purification media for actinobacteria 
GYM Medium  
 
Glucose  
Yeast extract  
Malt extract  
CaCO3  
Agar 
Deionized Water  
 
Maintenance and reactivation 
 
4.0 g/l  
4.0 g/l  
10.0 g/l  
2.0 g/l  
12 g/l  
1000 ml  
5336 + cyclo 
 
Soluble starch  
Casein (Pepton Typ M)  
K2HPO4  
MgSO4 x 7 H2O  
Agar  
Deionized water  
Cyclohexamide solution (50 mg/ml in 
methanol) added after autoclave 
 
Actinobacteria isolation medium  
 
10.0 g/l  
1.0 g/l  
0.5 g/l  
5.0 g/l  




Non-Streptomyces isolation medium 
Humic Acid-Vitamin Agar (HV) 
 





























0.5mg each of thiamine-HCl, 
riboflavin, niacin, pyridoxin-
HC1, inositol, Ca-pantothenate, 
p- aminobenzoic acid, and 
0.25mg of biotin 
7.2 
ISP medium (International Streptomyces Project)  
ISP2/ Yeast malt agar  
 
Malt extract  
Yeast extract  
Glucose  
Agar  
Maintenance and taxonomy  
 
10.0 g/l  
4.0 g/l  
4.0 g/l  
15.0 g/l  
101 
 
Deionized Water  
pH 
 
1000 ml  
7  
ISP3/ Oat meal agar  
 
Oatmeal (Quaker white oats)  
Agar  
Deionized Water  
Trace salt solution  
pH 
 
Maintenance and taxonomy  
 
20.0 g/l  
18.0 g/l  
1000 ml  
1 ml  
7.2  
(Trace salt solution ISP3)  
FeSO4 x 7H2O  
MnCl2 x 4H2O  
ZnSO4 x 7H2O  
Deionized water  
 
 
0.1 g  
0.1 g  
0.1 g  
100ml  
ISP 4  
 
Soluble starch  
(NH4)2SO4  
K2HPO4  




Deionized Water  
pH 
 
Maintenance and taxonomy  
 
10.0 g/l  
2.0 g/l  
1.0 g/l  
1.0 g/l  
1.0 g/l  
2.0 g/l  
20.0 g/l  







Trace salt solution  
Agar  
Deionized Water  
pH 
 
Maintenance and taxonomy  
 
1.0 g/l  
10.0 g/l  
1 g/l  
1ml/l  
20 g/l  
1000 ml  
7.2  
(Trace salt solution ISP5)  
FeSO4 x 7 H2O  
MnCl2 x 4 H2O  




1.0 g  
1.0 g  
1.0 g  
100ml 
ISP6 / Peptone Iron Agar  
 
Peptone  
Proteose Peptone  
Ferric ammonium citrate  
Sodium glycerophosphate  
Sodium thiosulfate-5-hydrate  
Yeast extract  
Agar  
Production of melanoid pigment  
 
15.0 g/l  
5.0 g/l  
0.5 g/l  
1.0 g/l  
0.126 g/l  
1.0 g/l  
20 g/l  
102 
 
Deionized Water  
pH 
 
1000 ml  
7.2  







FeSO4 x 7 H2O  
Trace Salt solution (5343)  
Agar  
Deionized water  
pH 
 
Production of melanoid pigment 
 
15 g/l  
0.5 g/l  
1.0 g/l  
0.5 g/l  
0.5 g/l  
0.01 g/l  
1.0 ml/l  




FeSO4 x 7 H2O  
ZnSO4 x 7 H2O  
MnCl2 x 4 H2O  
Deionized water 
  
Trace element solution 4  
1 g/l  
1 g/l  
1 g/l  
1000 ml  









MgSO4 x 7 H2O  
Trace element solution 2 (5341)  
Agar  
 
-Control medium is prepared without 
tyrosine (SSM-T) 
 
Production of melanoid pigment  
 
15.0 g/l  
1.0 g/l  
5.0 g/l  
5.0 g/l  
0.3 g/l  
0.3 g/l  
0.5 g/l  
0.2 g/l  
1.0 ml/l  
20 g/l  
5341  
CuSO4 x 5 H2O  
CaCl2 x 2 H2O  
FeSO4 x 7 H2O  
ZnSO4 x 7 H2O  
MnSO4 x 7 H2O  
Deionized water  
 
Trace element solution 2  
10.0 g/l  
10 g/l  
10 g/l  
10 g/l  
40 g/l  
1000 ml  
 
Production media 




(Metabolite production)  
 
15.0 g/l  
15.0 g/l  
103 
 
Corn steep liquor  
CaCO3  
NaCl  
Deionized water  
pH 
 
5.0 g/l  
2.0 g/l  
5.0 g/l  
1000 ml  
7.0  
Medium 5294  
 
Starch (soluble)  
Yeast extract  
Glucose  
Glycerol  
Corn steep liquor  
Peptone (Marcor S)  
NaCl  
CaCO3  





10.0 g/l  
2 g/l  
10 g/l  
10 g/l  
2.5 g/l  
2.0 g/l  
1 g/l  
3.0 g/l  




Starch (soluble)  
Yeast extract  
K2HPO4 
MgSO4 x 7 H2O  




15 g/l  
4 g/l  
1 g/l  
0.5 g/l 
1000 ml  
7.0 









20 g/l  
20 g/l  
4 g/l  
1000 ml  
 
 
Isolation and purification media for myxobacteria 
Water-agar  
CaCl2 x 2H2O  
MgSO4 x 7H2O  
Hepes  





























The vitamin solution is sterilized by 
filtration and stored at 4°C 
 
ST21 -agar  
Solution A:  
K2HPO4  
yeast extract (Difco) or 1% baker´s yeast 
(see VY/2 medium)  
Agar  
Solution B:  
KNO3  
MgSO4 · 7H2O  
CaCl2 · 2H2O  
FeCl3  
MnSO4 · 7H2O  
Combine solutions A and B and add 1 ml 
















baker's yeast  
CaCl2 x 2H2O  
(vitamin B12)  
Hepes  
Agar (Difco)  
Sterilize vitamin B12 separately by 
filtration. Prepare and store yeast cells as 
autoclaved stock suspension (50 g baker's 
yeast/100 ml distilled water. adjust pH to 
6.5 and autoclave). Adjust pH of medium 
to 7.2 with KOH before. and after 










Metabolic production media for myxobacteria 
Myxovirescin - Medium 
 
Casein peptone 
CaCl2 x 2H2O 













P – Medium 
 
Peptone (Marcor M) 
Starch (Cerestar) 
Probion 
Yeast extract (Marcor typ 9000) 
CaCl2 x 2H2O 




















Soy flour (degreased) 
Glucose monohydrat 
Starch (Cerestar) 
Yeast extract (Marcor typ 9000) 
CaCl2 x 2H2O 
MgSO4 x 4H2O 
HEPES  














POL - Medium 
 
Probion 
Starch (Cerestar ) 
CaCl2 x 2H2O 
MgSO4 x 4H2O 












Table S-2 List of 80 isolated Actinobacteria 




NS1 Plant leaf (Mord) 
Streptomyces galilaeus 
100 
NS3 Almond tree soil 100 
NS49 Plant leaf (Mord) 100 
NS65 Plant leaf (Mord) 99.5 






NS8 Plant leaf (Mord) 100 
NS18 Plant leaf (Mord) 99.79 
NS24 Plant leaf (Mord) 99.76 











NS47 Plant leaf (Mord) 99.88 
NS51 Almond tree soil 99.88 
NS55 Almond tree soil 100 
NS13 Almond tree soil Streptomyces 
youssoufiensis 
99.78 
NS28 Almond tree soil 99.78 






NS20 Plant leaf (Mord) Streptomyces finlayi 100 







NS5 Lichen 99.22 
NS48 Almond tree soil Streptomyces alboniger 99.32 




NS33 Almond tree soil Streptomyces violarus 99.76 
NS40 Astragalus soil Streptomyces badius 98.55 
NS60 Lichen Streptomyces 
cinereospinus 
99.73 
NS63 Lichen 99.62 




NS61 Lichen Streptomyces pratensis 99.65 
NS36 Almond tree soil Lentzea violacea 98.9 
NS54 Almond tree soil Lentzea californiensis 100 





NS9 Safran soil Streptomyces galilaeus 100 
NS17 Safran soil Streptomyces roseolus 99.58 
Lorestan 
6NS1 Forest soil  Streptomyces griseus 99.88 









NS10 Sand  
Streptomyces griseus 
99.88 
NS21 Soil 99.88 
NS12 Sand  
Streptomyces tanashiensis 
99.88 
NS29 Soil 99.88 
NS14 Soil Streptomyces fragilis 99.52 
NS32 Sand  Streptomyces peucetius 99.84 




NS46 Soil Streptomyces pratensis 99.73 









NS43 Cocroach 99.38 
NS58 Cocroach 99.51 
Saravan 
6NS8 Soil   Streptomyces olivaceus 100 
6NS10 Soil  Streptomyces inddigenes 100 
Qeshm  




NS11 Soil 99.54 
NS53 Mangrove forest 99.63 
NS39 Mangrove forest Streptomyces indiaensis 99.1 
NS25 
Sand from silver 
island 










Sand from silver 
island 
pseudonocardia cypriaca 99.39 
Semnan 
NS62 Desert soil 
Streptomyces griseoflavus 
99.88 
NS64 Desert soil 99.87 
NS34 Desert soil Kribbella pittospori 99.88 
NS59 Desert soil  Streptomyces specialis 98.03 
Isfahan 
NS38 Desert soil Nonomuraea harbinensis 99.62 








44ZA Desert soil Sanguibacter keddieii 98.34 
BA Desert soil Agromyces arachidis 99.58 
441B Desert soil Goordonia alkanivomans 100 
sef Desert soil Prauserella alba 100 
SO Desert soil Dietzia maris 99.7 
44MX Desert soil Jonesia  quighaiensis 100 
44Z Desert soil Microccus aloverae 100 
Kerman 



















Figure S1 Dendrogram obtained by cluster analysis of MALDI-TOF MS spectra of Q1 and Q2. 
Five type strains of each species were analyzed. Distance is displayed in relative units. 
 
                
             





                          
                                 
Figure S3 Results of A) temperature, B) pH, C) salt and D) carbon utilisation of Q2 
 
   
Figure S4 ISP plates of Q1 (left) A)GYM, B)ISP2, C)ISP3, D)ISP4, E)ISP5, F)ISP7 (right) A)ISP6, 
B)ISP7, C)SSM+, D) SSM- 
   
Figure S5 ISP plates of Q1 (left) A)GYM, B)ISP2, C)ISP3, D)ISP4, E)ISP5, F)ISP7 (right) A)ISP6, 
B)ISP7, C)SSM+, D)SSM- 



















                       
   
 
 







          
Figure S9 Identified polar lipids in Q1 (A) and Q2 (B) 
 
  
Figure S10 Results of salt and carbon utilisation of strain NS44ZA 
  





Figure S12 Identified polar lipids in strain A) NS44ZA and B) BA 
            
Figure S13 Identified A) Sugars and B) Aminoacids in strains NS44ZA and BA 
 







Figure S15 ISP plates of 4NS15 and type strains (left) A)GYM, B)ISP2, C)ISP3, D)ISP4, E)ISP5, 




Figure S16 Enzyme activity of strain 4NS15 and related type strains 
 
Figure S17 Two-dimensional thin-layer chromatogram of the polar lipids from strain 4NS15T 
detected with reagents: molybdophosphoric acid reagent (A), molybdenum blue spray reagent (B), 
ninhydrin reagent (C), a-naphthol reagent (D). DPG, diphosphatidylglycerol; PE, 
phosphatidylethanolamine; PE-OH, phosphatidylhydroxyethanolamine; AL, aminolipid; GAL, 






   
Figure S18 Results of temperature, pH, salt and carbon utilisation of strain NS59 
 
   







Figure S20 Strain NS25, A) Fractionation result by HPLC; B) HPLC chromatogram and active 












Figure S21 Strain NS59, A) Fractionation result by HPLC; B) HPLC chromatogram and active 

























Figure S24 ISP plates of NS40 and type strains (left) A)GYM, B)ISP2, C)ISP3, D)ISP4, E)ISP5, 


















Figure S27 LC–MS spectra of the family of compounds in active area with specific UV absorption 











Figure S29 Bacterial taxonomic profile of three freshwater snails of Lymnaea baltica, Lymnaea 





   
Figure S30 Results of pH, salt and carbon utilisation of 7NS3 
 
 
Figure S31 ISP plates of strain 7NS3 
 
              
Figure S32 Results of identified amino acids, sugars and polar lipids in strain 7NS3 (A= Amino 
acid TLC plate, B= Sugar results, C= Polar lipids TLC plate) 




Figure S33 Extracted ion chromatogram 200–640 nm for peaks 1– 4. 1: m/z 289.0858 (M+H)+, 
retention time (tR) = 10.39 min, 2: m/z 307.0966 (M+H)+, m/z 329.0785 (M+Na)+, m/z 289.0859 
(MH+–H2O), tR = 10.49 min, 3: m/z 309.1118 (M+H)+, m/z 331.0939 (M+Na)+, m/z 291.1014 (MH+– 
H2O), tR = 11.71 min and 4: m/z 256.2635 (M+H)+, m/z 278.2453 (M+Na)+, m/z 237.2212 (MH+–





Figure S34. List of predicted secondary metabolite gene clusters for strain 7NS3 identified by 
analysis of the 7NS3 genome sequence with the bioinformatic tool antiSMASH 5.0 
